PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Elf1
|
ENSMUSG00000036461.17 | Elf1 |
Elf2
|
ENSMUSG00000037174.19 | Elf2 |
Etv2
|
ENSMUSG00000006311.9 | Etv2 |
Elf4
|
ENSMUSG00000031103.13 | Elf4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Elf1 | mm39_v1_chr14_+_79753055_79753148 | 0.92 | 1.5e-30 | Click! |
Elf4 | mm39_v1_chrX_-_47543029_47543071 | 0.87 | 1.8e-23 | Click! |
Elf2 | mm39_v1_chr3_-_51184730_51184866 | 0.55 | 6.6e-07 | Click! |
Etv2 | mm39_v1_chr7_-_30335277_30335277 | -0.11 | 3.4e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_133617824 | 41.56 |
ENSMUST00000189524.2
ENSMUST00000169295.8 |
Lax1
|
lymphocyte transmembrane adaptor 1 |
chr3_-_89325594 | 35.73 |
ENSMUST00000029679.4
|
Cks1b
|
CDC28 protein kinase 1b |
chr6_+_124986078 | 34.96 |
ENSMUST00000054553.11
|
Zfp384
|
zinc finger protein 384 |
chr9_-_44920899 | 34.93 |
ENSMUST00000102832.3
|
Cd3e
|
CD3 antigen, epsilon polypeptide |
chr16_+_48814548 | 34.06 |
ENSMUST00000117994.8
ENSMUST00000048374.6 |
Cip2a
|
cell proliferation regulating inhibitor of protein phosphatase 2A |
chr7_+_126895463 | 33.59 |
ENSMUST00000106306.9
ENSMUST00000120857.8 |
Itgal
|
integrin alpha L |
chr16_-_18630722 | 32.62 |
ENSMUST00000000028.14
ENSMUST00000115585.2 |
Cdc45
|
cell division cycle 45 |
chrX_-_100311824 | 31.89 |
ENSMUST00000033664.14
|
Il2rg
|
interleukin 2 receptor, gamma chain |
chr6_+_124986193 | 31.55 |
ENSMUST00000112428.8
|
Zfp384
|
zinc finger protein 384 |
chr11_+_72851989 | 31.40 |
ENSMUST00000163326.8
ENSMUST00000108485.9 ENSMUST00000021142.8 ENSMUST00000108486.8 ENSMUST00000108484.8 |
Atp2a3
|
ATPase, Ca++ transporting, ubiquitous |
chr6_+_124986224 | 30.16 |
ENSMUST00000112427.8
|
Zfp384
|
zinc finger protein 384 |
chr7_+_126895423 | 30.16 |
ENSMUST00000117762.8
|
Itgal
|
integrin alpha L |
chr19_+_10554799 | 29.53 |
ENSMUST00000237564.2
ENSMUST00000236743.2 ENSMUST00000235271.2 ENSMUST00000168445.2 ENSMUST00000237641.2 ENSMUST00000236352.2 |
Cyb561a3
|
cytochrome b561 family, member A3 |
chr11_-_52173391 | 29.19 |
ENSMUST00000086844.10
|
Tcf7
|
transcription factor 7, T cell specific |
chr6_+_120341055 | 28.92 |
ENSMUST00000005108.10
|
Kdm5a
|
lysine (K)-specific demethylase 5A |
chr3_+_106389732 | 27.99 |
ENSMUST00000029508.11
|
Dennd2d
|
DENN/MADD domain containing 2D |
chr7_-_126391388 | 27.59 |
ENSMUST00000206570.2
|
Ppp4c
|
protein phosphatase 4, catalytic subunit |
chr19_+_10554845 | 27.57 |
ENSMUST00000237581.2
|
Cyb561a3
|
cytochrome b561 family, member A3 |
chr15_-_54953819 | 27.11 |
ENSMUST00000110231.2
ENSMUST00000023059.13 |
Dscc1
|
DNA replication and sister chromatid cohesion 1 |
chr19_+_6135013 | 27.04 |
ENSMUST00000025704.3
|
Cdca5
|
cell division cycle associated 5 |
chr19_+_10554510 | 26.93 |
ENSMUST00000237814.2
|
Cyb561a3
|
cytochrome b561 family, member A3 |
chr6_-_8259098 | 26.85 |
ENSMUST00000012627.5
|
Rpa3
|
replication protein A3 |
chr15_-_66432938 | 26.72 |
ENSMUST00000048372.7
|
Tmem71
|
transmembrane protein 71 |
chr3_+_87754310 | 26.52 |
ENSMUST00000029709.7
|
Sh2d2a
|
SH2 domain containing 2A |
chr6_+_117883783 | 26.48 |
ENSMUST00000177918.8
ENSMUST00000163168.9 |
Hnrnpf
|
heterogeneous nuclear ribonucleoprotein F |
chr2_+_24257576 | 26.37 |
ENSMUST00000140547.2
ENSMUST00000102942.8 |
Psd4
|
pleckstrin and Sec7 domain containing 4 |
chr7_-_126641593 | 26.27 |
ENSMUST00000032915.8
|
Kif22
|
kinesin family member 22 |
chr2_-_167334746 | 26.24 |
ENSMUST00000109211.9
ENSMUST00000057627.16 |
Spata2
|
spermatogenesis associated 2 |
chr6_+_117883732 | 26.21 |
ENSMUST00000179224.8
ENSMUST00000035493.14 |
Hnrnpf
|
heterogeneous nuclear ribonucleoprotein F |
chr4_-_129467430 | 25.91 |
ENSMUST00000102596.8
|
Lck
|
lymphocyte protein tyrosine kinase |
chr1_-_171434882 | 25.88 |
ENSMUST00000111277.2
ENSMUST00000004827.14 |
Ly9
|
lymphocyte antigen 9 |
chr19_-_11243530 | 25.85 |
ENSMUST00000169159.3
|
Ms4a1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr16_-_19801781 | 25.73 |
ENSMUST00000058839.10
|
Klhl6
|
kelch-like 6 |
chr17_+_35413415 | 25.56 |
ENSMUST00000025262.6
ENSMUST00000173600.2 |
Ltb
|
lymphotoxin B |
chr7_-_83304698 | 25.31 |
ENSMUST00000145610.8
|
Il16
|
interleukin 16 |
chr4_-_63321591 | 25.30 |
ENSMUST00000035724.5
|
Akna
|
AT-hook transcription factor |
chr2_+_156681991 | 25.25 |
ENSMUST00000073352.10
|
Tgif2
|
TGFB-induced factor homeobox 2 |
chr17_+_45866618 | 25.18 |
ENSMUST00000024742.9
ENSMUST00000233929.2 |
Nfkbie
|
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, epsilon |
chr17_+_34311314 | 24.22 |
ENSMUST00000025192.8
|
H2-Oa
|
histocompatibility 2, O region alpha locus |
chr13_-_17979675 | 24.08 |
ENSMUST00000223490.2
|
Cdk13
|
cyclin-dependent kinase 13 |
chr4_+_102971581 | 24.04 |
ENSMUST00000106858.8
|
Mier1
|
MEIR1 treanscription regulator |
chr11_+_61017573 | 23.90 |
ENSMUST00000010286.8
ENSMUST00000146033.8 ENSMUST00000139422.8 |
Tnfrsf13b
|
tumor necrosis factor receptor superfamily, member 13b |
chrX_+_99669343 | 23.82 |
ENSMUST00000048962.4
|
Kif4
|
kinesin family member 4 |
chr4_-_122779698 | 23.74 |
ENSMUST00000069533.12
|
Cap1
|
CAP, adenylate cyclase-associated protein 1 (yeast) |
chr2_+_109111083 | 23.64 |
ENSMUST00000028527.8
|
Kif18a
|
kinesin family member 18A |
chr1_+_135060431 | 23.59 |
ENSMUST00000187985.7
ENSMUST00000049449.11 |
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr11_-_94544748 | 23.59 |
ENSMUST00000039949.5
|
Eme1
|
essential meiotic structure-specific endonuclease 1 |
chr9_+_44893077 | 23.42 |
ENSMUST00000034602.9
|
Cd3d
|
CD3 antigen, delta polypeptide |
chr9_-_57743989 | 22.94 |
ENSMUST00000164010.8
ENSMUST00000171444.8 ENSMUST00000098686.4 |
Arid3b
|
AT rich interactive domain 3B (BRIGHT-like) |
chr3_-_90603013 | 22.73 |
ENSMUST00000069960.12
ENSMUST00000117167.2 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr19_-_4240984 | 22.63 |
ENSMUST00000045864.4
|
Tbc1d10c
|
TBC1 domain family, member 10c |
chr3_+_145630017 | 22.51 |
ENSMUST00000029842.9
|
Bcl10
|
B cell leukemia/lymphoma 10 |
chr4_-_122779742 | 22.06 |
ENSMUST00000128485.2
|
Cap1
|
CAP, adenylate cyclase-associated protein 1 (yeast) |
chr2_+_5850053 | 22.06 |
ENSMUST00000127116.7
ENSMUST00000194933.2 |
Nudt5
|
nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
chr19_-_4241034 | 21.98 |
ENSMUST00000237495.2
|
Tbc1d10c
|
TBC1 domain family, member 10c |
chr8_+_70261323 | 21.88 |
ENSMUST00000036074.15
ENSMUST00000123453.2 |
Gmip
|
Gem-interacting protein |
chr2_-_164197987 | 21.78 |
ENSMUST00000165980.2
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr1_-_85526517 | 21.69 |
ENSMUST00000093508.7
|
Sp110
|
Sp110 nuclear body protein |
chr1_+_171216480 | 21.62 |
ENSMUST00000056449.9
|
Arhgap30
|
Rho GTPase activating protein 30 |
chr7_+_126895531 | 21.45 |
ENSMUST00000170971.8
|
Itgal
|
integrin alpha L |
chr19_-_6996791 | 21.08 |
ENSMUST00000040772.9
|
Fermt3
|
fermitin family member 3 |
chr5_-_142891686 | 21.02 |
ENSMUST00000106216.3
|
Actb
|
actin, beta |
chr19_+_10502612 | 20.92 |
ENSMUST00000237321.2
ENSMUST00000038379.5 |
Cpsf7
|
cleavage and polyadenylation specific factor 7 |
chr1_-_192883743 | 20.74 |
ENSMUST00000043550.11
|
Traf3ip3
|
TRAF3 interacting protein 3 |
chr7_+_24069680 | 20.70 |
ENSMUST00000205428.2
ENSMUST00000171904.3 ENSMUST00000205626.2 |
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr7_-_140680437 | 20.61 |
ENSMUST00000210167.2
ENSMUST00000209294.2 ENSMUST00000097958.3 |
Sigirr
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr19_-_9876815 | 20.53 |
ENSMUST00000237147.2
ENSMUST00000025562.9 |
Incenp
|
inner centromere protein |
chr2_-_23045876 | 20.44 |
ENSMUST00000028119.7
|
Mastl
|
microtubule associated serine/threonine kinase-like |
chr17_-_24292453 | 20.35 |
ENSMUST00000017090.6
|
Kctd5
|
potassium channel tetramerisation domain containing 5 |
chr1_-_192883642 | 20.14 |
ENSMUST00000192020.6
|
Traf3ip3
|
TRAF3 interacting protein 3 |
chr11_+_54413698 | 20.10 |
ENSMUST00000108895.8
ENSMUST00000101206.10 |
Rapgef6
|
Rap guanine nucleotide exchange factor (GEF) 6 |
chr5_-_142891565 | 20.05 |
ENSMUST00000171419.8
|
Actb
|
actin, beta |
chr10_+_61133549 | 20.02 |
ENSMUST00000219375.2
|
Prf1
|
perforin 1 (pore forming protein) |
chr17_+_34362281 | 19.95 |
ENSMUST00000236519.2
|
H2-DMb2
|
histocompatibility 2, class II, locus Mb2 |
chr1_+_172204109 | 19.77 |
ENSMUST00000052455.4
|
Pigm
|
phosphatidylinositol glycan anchor biosynthesis, class M |
chr4_-_45320579 | 19.76 |
ENSMUST00000030003.10
|
Exosc3
|
exosome component 3 |
chr7_+_24596806 | 19.72 |
ENSMUST00000003469.8
|
Cd79a
|
CD79A antigen (immunoglobulin-associated alpha) |
chr2_-_163486998 | 19.69 |
ENSMUST00000017851.4
|
Serinc3
|
serine incorporator 3 |
chr6_+_129374260 | 19.63 |
ENSMUST00000032262.14
|
Clec1b
|
C-type lectin domain family 1, member b |
chrX_+_106299484 | 19.63 |
ENSMUST00000101294.9
ENSMUST00000118820.8 ENSMUST00000120971.8 |
Gpr174
|
G protein-coupled receptor 174 |
chr8_+_3715747 | 19.62 |
ENSMUST00000014118.4
|
Mcemp1
|
mast cell expressed membrane protein 1 |
chr1_-_133537953 | 19.57 |
ENSMUST00000164574.2
ENSMUST00000166291.8 ENSMUST00000164096.2 ENSMUST00000166915.8 |
Snrpe
|
small nuclear ribonucleoprotein E |
chr11_+_54413673 | 19.48 |
ENSMUST00000102743.10
|
Rapgef6
|
Rap guanine nucleotide exchange factor (GEF) 6 |
chr1_-_171434944 | 19.46 |
ENSMUST00000068878.14
|
Ly9
|
lymphocyte antigen 9 |
chr7_-_126641565 | 19.45 |
ENSMUST00000205806.2
|
Kif22
|
kinesin family member 22 |
chr11_+_54413772 | 19.40 |
ENSMUST00000207429.2
|
Rapgef6
|
Rap guanine nucleotide exchange factor (GEF) 6 |
chr2_-_164198427 | 19.33 |
ENSMUST00000109367.10
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr3_+_87754057 | 19.31 |
ENSMUST00000107581.9
|
Sh2d2a
|
SH2 domain containing 2A |
chr10_+_127159609 | 19.28 |
ENSMUST00000069548.7
|
Arhgap9
|
Rho GTPase activating protein 9 |
chr1_+_165616250 | 19.26 |
ENSMUST00000161971.8
ENSMUST00000187313.7 ENSMUST00000178336.8 ENSMUST00000005907.12 ENSMUST00000027849.11 |
Cd247
|
CD247 antigen |
chr11_-_52165682 | 19.03 |
ENSMUST00000238914.2
|
Tcf7
|
transcription factor 7, T cell specific |
chr11_-_6470918 | 18.98 |
ENSMUST00000003459.4
|
Myo1g
|
myosin IG |
chr17_+_35460722 | 18.79 |
ENSMUST00000068056.12
ENSMUST00000174757.8 ENSMUST00000173731.8 |
Ddx39b
|
DEAD box helicase 39b |
chr19_+_10502679 | 18.63 |
ENSMUST00000235674.2
|
Cpsf7
|
cleavage and polyadenylation specific factor 7 |
chr9_+_55997246 | 18.44 |
ENSMUST00000059206.8
|
Pstpip1
|
proline-serine-threonine phosphatase-interacting protein 1 |
chr7_+_43086432 | 18.40 |
ENSMUST00000070518.4
|
Nkg7
|
natural killer cell group 7 sequence |
chr9_+_65816206 | 18.26 |
ENSMUST00000205379.2
ENSMUST00000206048.2 ENSMUST00000034949.10 ENSMUST00000154589.2 |
Csnk1g1
|
casein kinase 1, gamma 1 |
chr8_+_84682136 | 18.21 |
ENSMUST00000005607.9
|
Asf1b
|
anti-silencing function 1B histone chaperone |
chr11_-_79414542 | 18.18 |
ENSMUST00000179322.2
|
Evi2b
|
ecotropic viral integration site 2b |
chr13_-_41640757 | 18.17 |
ENSMUST00000021794.14
|
Nedd9
|
neural precursor cell expressed, developmentally down-regulated gene 9 |
chr8_+_95744320 | 18.09 |
ENSMUST00000051259.10
|
Adgrg3
|
adhesion G protein-coupled receptor G3 |
chr17_-_57501170 | 18.07 |
ENSMUST00000005976.8
|
Tnfsf14
|
tumor necrosis factor (ligand) superfamily, member 14 |
chr12_-_21423607 | 18.01 |
ENSMUST00000064536.13
|
Adam17
|
a disintegrin and metallopeptidase domain 17 |
chr10_+_127159568 | 17.99 |
ENSMUST00000219026.2
|
Arhgap9
|
Rho GTPase activating protein 9 |
chr19_-_6996696 | 17.95 |
ENSMUST00000236188.2
|
Fermt3
|
fermitin family member 3 |
chr11_+_69856222 | 17.94 |
ENSMUST00000018713.13
|
Cldn7
|
claudin 7 |
chr19_+_4204605 | 17.90 |
ENSMUST00000061086.9
|
Ptprcap
|
protein tyrosine phosphatase, receptor type, C polypeptide-associated protein |
chr4_-_118294521 | 17.84 |
ENSMUST00000006565.13
|
Cdc20
|
cell division cycle 20 |
chr9_-_70328816 | 17.84 |
ENSMUST00000034742.8
|
Ccnb2
|
cyclin B2 |
chr17_-_34174631 | 17.80 |
ENSMUST00000174609.9
ENSMUST00000008812.9 |
Rps18
|
ribosomal protein S18 |
chr10_+_79824418 | 17.79 |
ENSMUST00000004784.11
ENSMUST00000105374.2 |
Cnn2
|
calponin 2 |
chr14_-_70412804 | 17.68 |
ENSMUST00000143393.2
|
Pdlim2
|
PDZ and LIM domain 2 |
chr18_-_35873493 | 17.66 |
ENSMUST00000235495.2
ENSMUST00000237919.2 ENSMUST00000237405.2 |
Sting1
|
stimulator of interferon response cGAMP interactor 1 |
chr12_-_11315755 | 17.63 |
ENSMUST00000166117.4
ENSMUST00000219600.2 ENSMUST00000218487.2 |
Gen1
|
GEN1, Holliday junction 5' flap endonuclease |
chr17_-_29483075 | 17.61 |
ENSMUST00000024802.10
|
Ppil1
|
peptidylprolyl isomerase (cyclophilin)-like 1 |
chr14_+_70337540 | 17.59 |
ENSMUST00000022680.9
|
Bin3
|
bridging integrator 3 |
chr11_-_106278892 | 17.48 |
ENSMUST00000106813.9
ENSMUST00000141146.2 |
Icam2
|
intercellular adhesion molecule 2 |
chr7_-_125968653 | 17.43 |
ENSMUST00000205642.2
ENSMUST00000032997.8 ENSMUST00000206793.2 |
Lat
|
linker for activation of T cells |
chrX_-_7956682 | 17.42 |
ENSMUST00000033505.7
|
Was
|
Wiskott-Aldrich syndrome |
chr4_-_59549314 | 17.40 |
ENSMUST00000148331.9
ENSMUST00000030076.12 |
Ptbp3
|
polypyrimidine tract binding protein 3 |
chr14_-_75991903 | 17.38 |
ENSMUST00000049168.9
|
Cog3
|
component of oligomeric golgi complex 3 |
chr2_+_28950250 | 17.38 |
ENSMUST00000100237.4
|
Ttf1
|
transcription termination factor, RNA polymerase I |
chr7_+_24602337 | 17.37 |
ENSMUST00000117796.8
ENSMUST00000047873.16 ENSMUST00000098683.11 ENSMUST00000206508.2 ENSMUST00000206028.2 |
Arhgef1
|
Rho guanine nucleotide exchange factor (GEF) 1 |
chr2_-_121001577 | 17.32 |
ENSMUST00000163766.8
ENSMUST00000146243.2 |
Zscan29
|
zinc finger SCAN domains 29 |
chr6_+_129374441 | 17.32 |
ENSMUST00000112081.9
ENSMUST00000112079.3 |
Clec1b
|
C-type lectin domain family 1, member b |
chr3_+_95566082 | 17.31 |
ENSMUST00000037947.15
ENSMUST00000178686.2 |
Mcl1
|
myeloid cell leukemia sequence 1 |
chr2_+_156681927 | 17.30 |
ENSMUST00000081335.13
|
Tgif2
|
TGFB-induced factor homeobox 2 |
chr12_-_21423524 | 17.12 |
ENSMUST00000232107.2
|
Adam17
|
a disintegrin and metallopeptidase domain 17 |
chr4_-_129452148 | 17.10 |
ENSMUST00000167288.8
ENSMUST00000134336.3 |
Lck
|
lymphocyte protein tyrosine kinase |
chr13_+_17869727 | 17.09 |
ENSMUST00000221480.2
|
Mplkip
|
M-phase specific PLK1 intereacting protein |
chr3_+_89325750 | 17.07 |
ENSMUST00000039110.12
ENSMUST00000125036.8 ENSMUST00000191485.7 ENSMUST00000154791.8 |
Shc1
|
src homology 2 domain-containing transforming protein C1 |
chr2_-_5017526 | 17.07 |
ENSMUST00000027980.8
|
Mcm10
|
minichromosome maintenance 10 replication initiation factor |
chr9_-_20864096 | 17.06 |
ENSMUST00000004202.17
|
Dnmt1
|
DNA methyltransferase (cytosine-5) 1 |
chr5_+_45827249 | 17.04 |
ENSMUST00000117396.3
|
Ncapg
|
non-SMC condensin I complex, subunit G |
chr19_-_4109446 | 16.97 |
ENSMUST00000189808.7
|
Gstp3
|
glutathione S-transferase pi 3 |
chr2_-_126341757 | 16.95 |
ENSMUST00000040128.12
|
Atp8b4
|
ATPase, class I, type 8B, member 4 |
chr7_-_121732067 | 16.94 |
ENSMUST00000106469.8
ENSMUST00000063587.13 ENSMUST00000106468.7 ENSMUST00000098068.10 |
Palb2
|
partner and localizer of BRCA2 |
chr4_-_129452180 | 16.88 |
ENSMUST00000067240.11
|
Lck
|
lymphocyte protein tyrosine kinase |
chr7_-_24459736 | 16.86 |
ENSMUST00000063956.7
|
Cd177
|
CD177 antigen |
chr2_-_130021229 | 16.85 |
ENSMUST00000103199.9
|
Snrpb
|
small nuclear ribonucleoprotein B |
chr11_-_99045894 | 16.84 |
ENSMUST00000103134.4
|
Ccr7
|
chemokine (C-C motif) receptor 7 |
chr5_-_107873883 | 16.83 |
ENSMUST00000159263.3
|
Gfi1
|
growth factor independent 1 transcription repressor |
chr3_-_130524024 | 16.81 |
ENSMUST00000079085.11
|
Rpl34
|
ribosomal protein L34 |
chr3_-_84489923 | 16.76 |
ENSMUST00000143514.3
|
Arfip1
|
ADP-ribosylation factor interacting protein 1 |
chr11_-_72441054 | 16.73 |
ENSMUST00000021154.7
|
Spns3
|
spinster homolog 3 |
chr5_+_97145533 | 16.72 |
ENSMUST00000112974.6
ENSMUST00000035635.10 |
Bmp2k
|
BMP2 inducible kinase |
chr7_+_119393210 | 16.62 |
ENSMUST00000033218.15
ENSMUST00000106520.9 |
Rexo5
|
RNA exonuclease 5 |
chr2_+_24276616 | 16.52 |
ENSMUST00000166388.2
|
Psd4
|
pleckstrin and Sec7 domain containing 4 |
chr3_+_90511068 | 16.50 |
ENSMUST00000001046.7
|
S100a4
|
S100 calcium binding protein A4 |
chr18_+_60907668 | 16.50 |
ENSMUST00000025511.11
|
Rps14
|
ribosomal protein S14 |
chr10_-_117628565 | 16.47 |
ENSMUST00000167943.8
ENSMUST00000064848.7 |
Nup107
|
nucleoporin 107 |
chr10_+_41352310 | 16.41 |
ENSMUST00000019967.16
ENSMUST00000119962.8 ENSMUST00000099934.11 |
Mical1
|
microtubule associated monooxygenase, calponin and LIM domain containing 1 |
chr2_+_152689881 | 16.33 |
ENSMUST00000164120.8
ENSMUST00000178997.8 ENSMUST00000109816.8 |
Tpx2
|
TPX2, microtubule-associated |
chr7_-_44203319 | 16.31 |
ENSMUST00000208366.2
ENSMUST00000207737.2 ENSMUST00000107910.8 ENSMUST00000167197.8 ENSMUST00000128600.3 ENSMUST00000107911.8 ENSMUST00000073488.12 |
Nr1h2
|
nuclear receptor subfamily 1, group H, member 2 |
chr14_-_31216949 | 16.29 |
ENSMUST00000228181.2
ENSMUST00000227777.2 ENSMUST00000227595.2 ENSMUST00000228727.2 ENSMUST00000055303.5 |
Mettl6
|
methyltransferase like 6 |
chr13_-_100912308 | 16.27 |
ENSMUST00000075550.4
|
Cenph
|
centromere protein H |
chrX_+_47235313 | 16.24 |
ENSMUST00000033427.7
|
Sash3
|
SAM and SH3 domain containing 3 |
chr9_-_32452885 | 16.21 |
ENSMUST00000016231.14
|
Fli1
|
Friend leukemia integration 1 |
chr2_+_118644717 | 16.21 |
ENSMUST00000028803.14
ENSMUST00000126045.8 |
Knstrn
|
kinetochore-localized astrin/SPAG5 binding |
chr18_+_60907698 | 16.15 |
ENSMUST00000118551.8
|
Rps14
|
ribosomal protein S14 |
chr19_-_10181243 | 16.15 |
ENSMUST00000142241.2
ENSMUST00000116542.9 ENSMUST00000025651.6 ENSMUST00000156291.2 |
Fen1
|
flap structure specific endonuclease 1 |
chr18_+_89195089 | 16.11 |
ENSMUST00000236644.2
ENSMUST00000236828.2 |
Cd226
|
CD226 antigen |
chr1_-_171061838 | 16.09 |
ENSMUST00000193973.2
|
Fcer1g
|
Fc receptor, IgE, high affinity I, gamma polypeptide |
chr8_+_70243813 | 16.05 |
ENSMUST00000034326.7
|
Atp13a1
|
ATPase type 13A1 |
chr19_+_41017714 | 16.02 |
ENSMUST00000051806.12
ENSMUST00000112200.3 |
Dntt
|
deoxynucleotidyltransferase, terminal |
chr15_-_5273659 | 16.01 |
ENSMUST00000047379.15
|
Ptger4
|
prostaglandin E receptor 4 (subtype EP4) |
chr8_-_105991219 | 15.98 |
ENSMUST00000034359.10
|
Tradd
|
TNFRSF1A-associated via death domain |
chr3_-_146227144 | 15.93 |
ENSMUST00000199079.2
ENSMUST00000029838.11 |
Rpf1
|
ribosome production factor 1 homolog |
chr1_-_138102972 | 15.90 |
ENSMUST00000195533.6
ENSMUST00000183301.8 |
Ptprc
|
protein tyrosine phosphatase, receptor type, C |
chr9_-_65487322 | 15.89 |
ENSMUST00000068944.9
|
Plekho2
|
pleckstrin homology domain containing, family O member 2 |
chr4_-_119177614 | 15.88 |
ENSMUST00000147077.8
ENSMUST00000056458.14 ENSMUST00000106321.9 ENSMUST00000106319.8 ENSMUST00000106317.2 ENSMUST00000106318.8 |
Ppih
|
peptidyl prolyl isomerase H |
chr18_-_80751327 | 15.88 |
ENSMUST00000236310.2
ENSMUST00000167977.8 ENSMUST00000035800.8 |
Nfatc1
|
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
chr19_-_46033353 | 15.83 |
ENSMUST00000026252.14
ENSMUST00000156585.9 ENSMUST00000185355.7 ENSMUST00000152946.8 |
Ldb1
|
LIM domain binding 1 |
chr7_+_43086554 | 15.76 |
ENSMUST00000206741.2
|
Nkg7
|
natural killer cell group 7 sequence |
chr8_+_106412905 | 15.68 |
ENSMUST00000213019.2
|
Carmil2
|
capping protein regulator and myosin 1 linker 2 |
chr10_+_128584324 | 15.68 |
ENSMUST00000065210.10
ENSMUST00000218218.2 |
Pym1
|
PYM homolog 1, exon junction complex associated factor |
chr11_+_61544085 | 15.68 |
ENSMUST00000004959.3
|
Grap
|
GRB2-related adaptor protein |
chr9_+_44966464 | 15.61 |
ENSMUST00000114664.8
|
Mpzl3
|
myelin protein zero-like 3 |
chr9_+_20927271 | 15.56 |
ENSMUST00000086399.6
|
Icam1
|
intercellular adhesion molecule 1 |
chr11_+_72889889 | 15.55 |
ENSMUST00000021141.14
|
P2rx1
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
chr5_-_31337453 | 15.53 |
ENSMUST00000202639.4
ENSMUST00000088010.12 |
Gtf3c2
|
general transcription factor IIIC, polypeptide 2, beta |
chr12_-_113223839 | 15.51 |
ENSMUST00000194738.6
ENSMUST00000178282.3 |
Igha
|
immunoglobulin heavy constant alpha |
chr15_-_5273645 | 15.44 |
ENSMUST00000120563.2
|
Ptger4
|
prostaglandin E receptor 4 (subtype EP4) |
chr13_-_58532990 | 15.31 |
ENSMUST00000022032.7
|
2210016F16Rik
|
RIKEN cDNA 2210016F16 gene |
chr17_-_57385490 | 15.31 |
ENSMUST00000011623.9
|
Dennd1c
|
DENN/MADD domain containing 1C |
chr15_+_6609322 | 15.29 |
ENSMUST00000090461.12
|
Fyb
|
FYN binding protein |
chr17_+_35268942 | 15.29 |
ENSMUST00000007257.10
|
Clic1
|
chloride intracellular channel 1 |
chr6_-_125168637 | 15.14 |
ENSMUST00000043848.11
|
Ncapd2
|
non-SMC condensin I complex, subunit D2 |
chr2_+_127178072 | 15.13 |
ENSMUST00000028846.7
|
Dusp2
|
dual specificity phosphatase 2 |
chr7_+_28140450 | 15.12 |
ENSMUST00000135686.2
|
Gmfg
|
glia maturation factor, gamma |
chr18_-_35873554 | 15.12 |
ENSMUST00000115728.5
|
Sting1
|
stimulator of interferon response cGAMP interactor 1 |
chr4_+_130643260 | 15.12 |
ENSMUST00000030316.7
|
Laptm5
|
lysosomal-associated protein transmembrane 5 |
chr17_-_34109513 | 15.06 |
ENSMUST00000173386.2
ENSMUST00000114361.9 ENSMUST00000173492.9 |
Kifc1
|
kinesin family member C1 |
chr19_-_5518515 | 15.00 |
ENSMUST00000236256.2
ENSMUST00000025844.6 |
Ctsw
|
cathepsin W |
chr9_-_20556031 | 14.96 |
ENSMUST00000148631.8
ENSMUST00000131128.2 ENSMUST00000151861.9 ENSMUST00000131343.8 ENSMUST00000086458.10 |
Fbxl12
|
F-box and leucine-rich repeat protein 12 |
chr1_+_171594690 | 14.94 |
ENSMUST00000015460.5
|
Slamf1
|
signaling lymphocytic activation molecule family member 1 |
chr3_+_89325901 | 14.94 |
ENSMUST00000128238.8
ENSMUST00000107417.9 |
Shc1
|
src homology 2 domain-containing transforming protein C1 |
chr7_+_142014546 | 14.92 |
ENSMUST00000105968.8
ENSMUST00000018963.11 ENSMUST00000105967.8 |
Lsp1
|
lymphocyte specific 1 |
chr1_-_121495623 | 14.84 |
ENSMUST00000001724.12
|
Ddx18
|
DEAD box helicase 18 |
chr17_-_80597495 | 14.83 |
ENSMUST00000086555.11
|
Dhx57
|
DEAH (Asp-Glu-Ala-Asp/His) box polypeptide 57 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.6 | 49.9 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
13.8 | 55.0 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
13.7 | 41.1 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
12.5 | 112.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
12.2 | 36.7 | GO:0033624 | negative regulation of integrin activation(GO:0033624) |
11.2 | 33.7 | GO:0043366 | beta selection(GO:0043366) |
11.1 | 33.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
10.6 | 31.9 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
10.2 | 10.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
9.6 | 57.5 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
9.5 | 9.5 | GO:0071226 | cellular response to molecule of fungal origin(GO:0071226) |
9.2 | 9.2 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
9.0 | 54.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
8.9 | 107.0 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
8.9 | 26.6 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
8.6 | 34.3 | GO:0070488 | neutrophil aggregation(GO:0070488) |
8.5 | 42.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
8.3 | 41.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
8.1 | 24.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
8.1 | 24.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
8.0 | 47.9 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
7.9 | 39.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
7.6 | 30.6 | GO:0010269 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) response to selenium ion(GO:0010269) |
7.6 | 30.4 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
7.5 | 7.5 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
7.4 | 74.0 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
7.3 | 21.9 | GO:0046038 | GMP catabolic process(GO:0046038) |
7.3 | 29.2 | GO:0032329 | serine transport(GO:0032329) |
7.2 | 65.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
7.1 | 35.6 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
7.1 | 21.2 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
6.9 | 34.3 | GO:1904171 | negative regulation of bleb assembly(GO:1904171) |
6.8 | 54.8 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
6.8 | 47.8 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
6.7 | 20.1 | GO:0071846 | actin filament debranching(GO:0071846) |
6.6 | 32.8 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
6.4 | 19.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
6.3 | 25.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
6.3 | 25.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
6.3 | 25.0 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
6.2 | 31.0 | GO:0030576 | Cajal body organization(GO:0030576) |
6.1 | 36.7 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
6.1 | 24.3 | GO:0017126 | nucleologenesis(GO:0017126) |
6.0 | 24.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
5.8 | 5.8 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
5.8 | 46.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
5.8 | 11.6 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
5.8 | 23.2 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
5.6 | 16.9 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
5.6 | 39.4 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
5.6 | 22.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
5.6 | 5.6 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
5.6 | 27.8 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
5.5 | 33.1 | GO:1990839 | response to endothelin(GO:1990839) |
5.5 | 16.4 | GO:0019417 | sulfur oxidation(GO:0019417) |
5.4 | 37.8 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
5.4 | 21.5 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
5.3 | 15.8 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
5.2 | 15.7 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
5.2 | 15.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
5.2 | 36.4 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
5.2 | 15.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
5.0 | 25.2 | GO:0009597 | detection of virus(GO:0009597) |
4.9 | 4.9 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
4.9 | 19.7 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
4.9 | 43.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
4.8 | 4.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
4.8 | 9.7 | GO:0036492 | regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
4.8 | 14.5 | GO:0036275 | response to 5-fluorouracil(GO:0036275) |
4.7 | 9.5 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
4.7 | 14.1 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
4.7 | 14.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
4.7 | 9.3 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
4.6 | 37.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
4.6 | 37.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
4.6 | 13.9 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
4.6 | 18.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
4.6 | 18.3 | GO:0046898 | response to cycloheximide(GO:0046898) |
4.6 | 36.5 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
4.5 | 9.1 | GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
4.5 | 13.6 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
4.5 | 13.5 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
4.5 | 13.4 | GO:0070839 | divalent metal ion export(GO:0070839) |
4.5 | 17.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
4.4 | 13.3 | GO:0070429 | regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
4.4 | 106.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
4.4 | 13.3 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
4.4 | 4.4 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
4.4 | 8.8 | GO:0019323 | pentose catabolic process(GO:0019323) |
4.4 | 4.4 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
4.4 | 39.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
4.4 | 26.2 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
4.3 | 34.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
4.3 | 13.0 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
4.3 | 17.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
4.3 | 13.0 | GO:1904582 | positive regulation of intracellular mRNA localization(GO:1904582) |
4.2 | 4.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
4.2 | 12.7 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
4.2 | 4.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
4.2 | 67.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
4.2 | 92.0 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
4.2 | 8.3 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
4.1 | 57.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
4.1 | 20.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
4.0 | 24.3 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
4.0 | 28.2 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
4.0 | 8.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
4.0 | 8.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
4.0 | 16.0 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
4.0 | 16.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
4.0 | 43.9 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
4.0 | 63.6 | GO:0001771 | immunological synapse formation(GO:0001771) |
3.9 | 11.8 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
3.9 | 11.8 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
3.9 | 70.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
3.9 | 23.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
3.9 | 11.7 | GO:0031627 | telomeric loop formation(GO:0031627) |
3.9 | 15.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
3.8 | 34.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
3.8 | 19.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
3.8 | 19.0 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
3.8 | 18.9 | GO:1901355 | response to rapamycin(GO:1901355) |
3.7 | 74.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
3.7 | 7.4 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
3.7 | 11.1 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) negative regulation of DNA demethylation(GO:1901536) |
3.7 | 11.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
3.7 | 3.7 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
3.7 | 54.9 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
3.7 | 11.0 | GO:0015898 | amiloride transport(GO:0015898) cellular response to copper ion starvation(GO:0035874) response to azide(GO:0097184) cellular response to azide(GO:0097185) |
3.7 | 18.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
3.6 | 10.9 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
3.6 | 21.9 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
3.6 | 29.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
3.6 | 14.5 | GO:0071988 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
3.6 | 18.0 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
3.6 | 10.8 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
3.6 | 14.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
3.6 | 39.2 | GO:0030220 | platelet formation(GO:0030220) |
3.6 | 14.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
3.5 | 3.5 | GO:0001743 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
3.5 | 14.2 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
3.5 | 14.0 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
3.5 | 10.5 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
3.4 | 13.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
3.4 | 119.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
3.4 | 13.6 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
3.4 | 6.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
3.4 | 3.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
3.4 | 6.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
3.4 | 10.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
3.3 | 6.7 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
3.3 | 6.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
3.3 | 9.9 | GO:1901738 | regulation of vitamin A metabolic process(GO:1901738) |
3.3 | 23.2 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
3.3 | 19.8 | GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
3.3 | 16.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
3.3 | 13.1 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
3.3 | 42.5 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
3.3 | 9.8 | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) double-strand break repair involved in meiotic recombination(GO:1990918) |
3.2 | 13.0 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) |
3.2 | 9.7 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
3.2 | 25.8 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
3.2 | 22.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
3.2 | 9.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
3.2 | 15.9 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
3.2 | 3.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
3.2 | 3.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
3.2 | 44.3 | GO:0080009 | mRNA methylation(GO:0080009) |
3.1 | 59.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
3.1 | 12.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
3.1 | 103.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
3.1 | 12.5 | GO:0010046 | response to mycotoxin(GO:0010046) |
3.1 | 15.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
3.1 | 12.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
3.1 | 12.2 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
3.0 | 9.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
3.0 | 33.5 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
3.0 | 12.2 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
3.0 | 9.1 | GO:0045004 | DNA replication proofreading(GO:0045004) |
3.0 | 14.9 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
2.9 | 32.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
2.9 | 11.8 | GO:0033575 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
2.9 | 8.8 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
2.9 | 55.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
2.9 | 14.5 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
2.9 | 8.7 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
2.9 | 25.9 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
2.9 | 11.5 | GO:1900191 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
2.9 | 11.5 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
2.9 | 22.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
2.9 | 8.6 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
2.8 | 14.2 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
2.8 | 17.0 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
2.8 | 36.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
2.8 | 2.8 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
2.8 | 28.2 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
2.8 | 5.6 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
2.8 | 11.2 | GO:0090135 | actin filament branching(GO:0090135) |
2.8 | 5.6 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
2.8 | 11.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
2.8 | 8.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
2.8 | 2.8 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
2.8 | 24.9 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
2.8 | 8.3 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
2.8 | 74.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
2.8 | 38.6 | GO:0070269 | pyroptosis(GO:0070269) |
2.7 | 11.0 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
2.7 | 10.9 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
2.7 | 10.8 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
2.7 | 18.9 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
2.7 | 5.4 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
2.7 | 2.7 | GO:0061009 | common bile duct development(GO:0061009) |
2.7 | 8.1 | GO:0035702 | monocyte homeostasis(GO:0035702) |
2.7 | 26.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
2.7 | 8.0 | GO:0032685 | negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) |
2.6 | 21.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
2.6 | 10.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
2.6 | 10.5 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
2.6 | 13.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
2.6 | 18.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
2.6 | 10.4 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
2.6 | 13.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
2.6 | 10.4 | GO:1902164 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
2.6 | 10.4 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
2.6 | 5.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
2.6 | 2.6 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) |
2.6 | 61.6 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
2.6 | 2.6 | GO:0034769 | basement membrane disassembly(GO:0034769) |
2.5 | 10.2 | GO:0060003 | copper ion export(GO:0060003) |
2.5 | 2.5 | GO:1901563 | response to camptothecin(GO:1901563) |
2.5 | 5.1 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
2.5 | 10.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
2.5 | 7.6 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
2.5 | 7.6 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
2.5 | 7.6 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
2.5 | 5.1 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
2.5 | 2.5 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
2.5 | 15.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
2.5 | 5.0 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
2.5 | 12.5 | GO:0032202 | telomere assembly(GO:0032202) |
2.5 | 27.5 | GO:0015074 | DNA integration(GO:0015074) |
2.5 | 7.5 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
2.5 | 12.4 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
2.5 | 5.0 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
2.5 | 7.4 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
2.5 | 22.2 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
2.5 | 4.9 | GO:0048254 | snoRNA localization(GO:0048254) |
2.5 | 41.8 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
2.4 | 185.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
2.4 | 14.6 | GO:0045346 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
2.4 | 7.3 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
2.4 | 9.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
2.4 | 9.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
2.4 | 7.2 | GO:0048320 | axial mesoderm formation(GO:0048320) |
2.4 | 9.6 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
2.4 | 7.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
2.4 | 21.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
2.3 | 7.0 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
2.3 | 58.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
2.3 | 4.6 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
2.3 | 25.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
2.3 | 6.9 | GO:0000494 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
2.3 | 4.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
2.3 | 9.2 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
2.3 | 9.2 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
2.3 | 22.8 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
2.3 | 9.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
2.3 | 4.5 | GO:0097017 | renal protein absorption(GO:0097017) |
2.3 | 2.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
2.3 | 13.6 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
2.3 | 2.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
2.2 | 4.5 | GO:0046967 | cytosol to ER transport(GO:0046967) |
2.2 | 6.7 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
2.2 | 22.4 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
2.2 | 2.2 | GO:0002481 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
2.2 | 6.7 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
2.2 | 2.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
2.2 | 28.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
2.2 | 13.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
2.2 | 17.6 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
2.2 | 8.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
2.2 | 6.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
2.2 | 10.9 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
2.2 | 15.2 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) |
2.1 | 36.5 | GO:0016180 | snRNA processing(GO:0016180) |
2.1 | 6.4 | GO:0061511 | centriole elongation(GO:0061511) |
2.1 | 2.1 | GO:0045608 | inhibition of neuroepithelial cell differentiation(GO:0002085) negative regulation of auditory receptor cell differentiation(GO:0045608) |
2.1 | 12.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
2.1 | 31.9 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
2.1 | 36.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
2.1 | 12.7 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
2.1 | 14.8 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
2.1 | 14.8 | GO:0015862 | uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
2.1 | 10.5 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
2.1 | 64.8 | GO:0019731 | antibacterial humoral response(GO:0019731) |
2.1 | 31.3 | GO:0006968 | cellular defense response(GO:0006968) |
2.1 | 6.2 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
2.1 | 12.5 | GO:0001878 | response to yeast(GO:0001878) |
2.1 | 12.5 | GO:0006116 | NADH oxidation(GO:0006116) |
2.1 | 6.2 | GO:0006233 | dTDP biosynthetic process(GO:0006233) dTDP metabolic process(GO:0046072) |
2.1 | 4.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
2.1 | 6.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
2.1 | 8.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
2.1 | 14.4 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
2.1 | 6.2 | GO:0051714 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
2.1 | 8.2 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
2.1 | 18.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
2.1 | 22.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
2.1 | 28.7 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
2.0 | 4.1 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
2.0 | 16.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.0 | 6.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
2.0 | 4.0 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
2.0 | 4.0 | GO:0002649 | regulation of tolerance induction to self antigen(GO:0002649) |
2.0 | 16.0 | GO:0051014 | actin filament severing(GO:0051014) |
2.0 | 4.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
2.0 | 6.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
2.0 | 6.0 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
2.0 | 6.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
2.0 | 8.0 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
2.0 | 8.0 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
2.0 | 13.9 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
2.0 | 31.7 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
2.0 | 2.0 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
2.0 | 39.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
2.0 | 7.9 | GO:0003162 | atrioventricular node development(GO:0003162) |
2.0 | 2.0 | GO:0060399 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
2.0 | 21.6 | GO:2001199 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
2.0 | 2.0 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
2.0 | 7.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.9 | 3.9 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
1.9 | 3.8 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
1.9 | 5.7 | GO:0036245 | cellular response to menadione(GO:0036245) |
1.9 | 3.8 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
1.9 | 5.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
1.9 | 1.9 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
1.9 | 7.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.9 | 5.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.9 | 11.4 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
1.9 | 3.8 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
1.9 | 9.5 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
1.9 | 5.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.9 | 26.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
1.9 | 15.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.9 | 13.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
1.9 | 5.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.9 | 13.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
1.9 | 5.6 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
1.9 | 18.5 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.8 | 75.8 | GO:0043029 | T cell homeostasis(GO:0043029) |
1.8 | 11.1 | GO:0072718 | response to cisplatin(GO:0072718) |
1.8 | 5.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.8 | 5.5 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.8 | 40.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.8 | 5.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.8 | 21.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.8 | 20.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
1.8 | 7.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.8 | 9.1 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
1.8 | 9.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
1.8 | 9.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
1.8 | 9.0 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
1.8 | 5.4 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.8 | 14.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
1.8 | 5.4 | GO:0097045 | activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) |
1.8 | 14.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
1.8 | 1.8 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.8 | 7.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
1.8 | 8.9 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) DNA demethylation of male pronucleus(GO:0044727) |
1.8 | 5.3 | GO:0045212 | neurotransmitter receptor biosynthetic process(GO:0045212) |
1.8 | 60.1 | GO:0030033 | microvillus assembly(GO:0030033) |
1.8 | 26.4 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
1.8 | 10.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
1.8 | 21.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
1.8 | 21.0 | GO:0097531 | mast cell migration(GO:0097531) |
1.8 | 14.0 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.7 | 5.2 | GO:0021660 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
1.7 | 10.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
1.7 | 1.7 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
1.7 | 12.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
1.7 | 13.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.7 | 1.7 | GO:1904172 | positive regulation of bleb assembly(GO:1904172) |
1.7 | 1.7 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.7 | 8.6 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
1.7 | 47.7 | GO:0034508 | centromere complex assembly(GO:0034508) |
1.7 | 18.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.7 | 11.9 | GO:0007144 | female meiosis I(GO:0007144) |
1.7 | 282.7 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.7 | 5.1 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
1.7 | 1.7 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.7 | 6.7 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
1.7 | 55.3 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
1.7 | 26.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.7 | 6.7 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) |
1.7 | 5.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.7 | 5.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
1.7 | 8.3 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
1.7 | 24.9 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
1.7 | 6.6 | GO:1990743 | protein sialylation(GO:1990743) |
1.7 | 58.0 | GO:0006284 | base-excision repair(GO:0006284) |
1.7 | 41.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
1.6 | 8.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
1.6 | 6.5 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
1.6 | 4.9 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
1.6 | 27.7 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
1.6 | 3.3 | GO:1902568 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) regulation of eosinophil activation(GO:1902566) positive regulation of eosinophil activation(GO:1902568) |
1.6 | 4.9 | GO:0061723 | glycophagy(GO:0061723) |
1.6 | 17.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.6 | 4.9 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.6 | 16.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.6 | 4.8 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
1.6 | 8.0 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
1.6 | 1.6 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
1.6 | 8.0 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
1.6 | 9.6 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
1.6 | 4.8 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
1.6 | 1.6 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.6 | 17.3 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
1.6 | 6.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.6 | 7.8 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
1.6 | 17.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
1.5 | 6.2 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
1.5 | 35.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
1.5 | 46.1 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
1.5 | 1.5 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
1.5 | 9.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.5 | 54.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.5 | 4.6 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
1.5 | 3.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
1.5 | 4.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.5 | 18.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
1.5 | 7.5 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
1.5 | 41.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
1.5 | 38.7 | GO:0007099 | centriole replication(GO:0007099) |
1.5 | 11.9 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
1.5 | 4.5 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
1.5 | 5.9 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
1.5 | 4.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.5 | 4.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.5 | 5.9 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
1.5 | 4.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.5 | 4.4 | GO:0071626 | mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
1.5 | 2.9 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
1.4 | 2.9 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
1.4 | 15.8 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
1.4 | 5.7 | GO:0097298 | regulation of nucleus size(GO:0097298) |
1.4 | 5.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.4 | 2.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.4 | 4.3 | GO:0007225 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
1.4 | 8.5 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
1.4 | 9.9 | GO:0016266 | O-glycan processing(GO:0016266) |
1.4 | 43.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.4 | 4.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
1.4 | 4.2 | GO:0001783 | B cell apoptotic process(GO:0001783) |
1.4 | 4.2 | GO:1904446 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of establishment of Sertoli cell barrier(GO:1904444) positive regulation of establishment of Sertoli cell barrier(GO:1904446) negative regulation of type B pancreatic cell development(GO:2000077) |
1.4 | 20.9 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
1.4 | 9.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.4 | 9.7 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
1.4 | 4.2 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
1.4 | 5.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.4 | 2.8 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
1.4 | 4.1 | GO:0033088 | regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.4 | 6.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.4 | 2.7 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
1.4 | 2.7 | GO:0006740 | NADPH regeneration(GO:0006740) |
1.4 | 15.0 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
1.4 | 4.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
1.4 | 12.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.4 | 1.4 | GO:1902941 | regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) |
1.4 | 5.4 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) |
1.3 | 31.0 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
1.3 | 5.4 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
1.3 | 8.1 | GO:0007296 | vitellogenesis(GO:0007296) |
1.3 | 21.5 | GO:0043248 | proteasome assembly(GO:0043248) |
1.3 | 6.7 | GO:1904970 | brush border assembly(GO:1904970) |
1.3 | 4.0 | GO:2000845 | positive regulation of testosterone secretion(GO:2000845) |
1.3 | 51.8 | GO:0034340 | response to type I interferon(GO:0034340) |
1.3 | 11.9 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
1.3 | 8.0 | GO:0015867 | ATP transport(GO:0015867) |
1.3 | 3.9 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
1.3 | 1.3 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
1.3 | 9.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
1.3 | 3.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.3 | 10.4 | GO:0006265 | DNA topological change(GO:0006265) |
1.3 | 5.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
1.3 | 5.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.3 | 3.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) positive regulation of neutrophil differentiation(GO:0045660) |
1.3 | 5.2 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
1.3 | 57.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
1.3 | 8.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
1.3 | 2.5 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
1.3 | 10.2 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.3 | 71.1 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
1.3 | 11.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
1.3 | 2.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
1.3 | 2.5 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
1.3 | 13.8 | GO:0060056 | mammary gland involution(GO:0060056) |
1.3 | 5.0 | GO:0003017 | lymph circulation(GO:0003017) |
1.2 | 57.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
1.2 | 7.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
1.2 | 4.9 | GO:1903232 | melanosome assembly(GO:1903232) |
1.2 | 13.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.2 | 34.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
1.2 | 18.3 | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition(GO:0045841) |
1.2 | 3.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
1.2 | 6.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.2 | 7.3 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
1.2 | 8.5 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
1.2 | 1.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
1.2 | 14.5 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
1.2 | 3.6 | GO:0072355 | histone H3-T3 phosphorylation(GO:0072355) |
1.2 | 7.2 | GO:0001510 | RNA methylation(GO:0001510) |
1.2 | 10.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.2 | 3.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.2 | 4.8 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
1.2 | 17.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
1.2 | 2.4 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
1.2 | 4.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.2 | 3.5 | GO:0044838 | cell quiescence(GO:0044838) |
1.2 | 10.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.2 | 17.6 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.2 | 29.2 | GO:0006491 | N-glycan processing(GO:0006491) |
1.2 | 5.8 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.2 | 1.2 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
1.2 | 9.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
1.2 | 4.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.2 | 48.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
1.2 | 3.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.2 | 3.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.2 | 2.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
1.2 | 3.5 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
1.1 | 17.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
1.1 | 2.3 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.1 | 1.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.1 | 9.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) negative regulation of podosome assembly(GO:0071802) |
1.1 | 5.7 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
1.1 | 5.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.1 | 3.4 | GO:0033505 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
1.1 | 10.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
1.1 | 5.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
1.1 | 4.5 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
1.1 | 9.0 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
1.1 | 7.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.1 | 4.5 | GO:0033373 | mast cell secretory granule organization(GO:0033364) protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
1.1 | 2.2 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
1.1 | 5.6 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
1.1 | 2.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
1.1 | 15.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
1.1 | 6.7 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
1.1 | 3.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
1.1 | 7.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.1 | 15.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.1 | 2.2 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
1.1 | 15.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
1.1 | 1.1 | GO:0042033 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
1.1 | 8.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
1.1 | 1.1 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
1.1 | 4.4 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
1.1 | 22.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
1.1 | 13.0 | GO:0051451 | myoblast migration(GO:0051451) |
1.1 | 4.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
1.1 | 21.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.1 | 7.4 | GO:0044351 | macropinocytosis(GO:0044351) |
1.1 | 3.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.0 | 3.1 | GO:0016240 | autophagosome docking(GO:0016240) |
1.0 | 26.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.0 | 6.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.0 | 6.3 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
1.0 | 3.1 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
1.0 | 3.1 | GO:0032218 | riboflavin transport(GO:0032218) |
1.0 | 13.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.0 | 39.5 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
1.0 | 5.2 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
1.0 | 53.6 | GO:0051225 | spindle assembly(GO:0051225) |
1.0 | 4.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.0 | 4.1 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
1.0 | 9.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
1.0 | 17.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.0 | 3.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
1.0 | 5.1 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
1.0 | 10.2 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
1.0 | 5.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.0 | 15.2 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
1.0 | 30.2 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
1.0 | 4.0 | GO:1903309 | negative regulation of chromatin modification(GO:1903309) |
1.0 | 3.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.0 | 9.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
1.0 | 21.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
1.0 | 5.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.0 | 11.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.0 | 5.9 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
1.0 | 19.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
1.0 | 5.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.0 | 6.9 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.0 | 3.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
1.0 | 3.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.0 | 2.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.0 | 5.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.0 | 1.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.0 | 8.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
1.0 | 22.4 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
1.0 | 1.9 | GO:2000011 | adaxial/abaxial pattern specification(GO:0009955) regulation of adaxial/abaxial pattern formation(GO:2000011) |
1.0 | 6.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.0 | 15.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
1.0 | 2.9 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
1.0 | 6.7 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
1.0 | 136.7 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
1.0 | 1.0 | GO:0072319 | vesicle uncoating(GO:0072319) |
1.0 | 15.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
1.0 | 18.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.0 | 5.7 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
1.0 | 6.7 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
0.9 | 1.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.9 | 0.9 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.9 | 8.5 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.9 | 4.7 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.9 | 1.9 | GO:0072021 | ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
0.9 | 0.9 | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
0.9 | 8.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.9 | 0.9 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.9 | 1.9 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.9 | 3.7 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.9 | 2.8 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.9 | 113.2 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.9 | 5.5 | GO:0014029 | neural crest formation(GO:0014029) |
0.9 | 1.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.9 | 0.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.9 | 13.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.9 | 8.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.9 | 7.3 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.9 | 4.5 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.9 | 19.0 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.9 | 0.9 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.9 | 0.9 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.9 | 3.6 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.9 | 17.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.9 | 3.6 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.9 | 9.0 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.9 | 1.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.9 | 17.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.9 | 9.9 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.9 | 0.9 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.9 | 2.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.9 | 7.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.9 | 7.0 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.9 | 4.4 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.9 | 13.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.9 | 1.7 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) |
0.9 | 5.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.9 | 0.9 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
0.9 | 30.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.9 | 1.7 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.9 | 13.8 | GO:0050779 | RNA destabilization(GO:0050779) |
0.9 | 10.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.9 | 3.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.9 | 6.0 | GO:1902748 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.9 | 4.3 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.9 | 13.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.9 | 2.6 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.9 | 0.9 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.9 | 6.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.8 | 2.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.8 | 0.8 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.8 | 9.3 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.8 | 6.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.8 | 10.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.8 | 3.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.8 | 4.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.8 | 1.7 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.8 | 14.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.8 | 0.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.8 | 60.4 | GO:0006413 | translational initiation(GO:0006413) |
0.8 | 2.5 | GO:0072642 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.8 | 0.8 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.8 | 0.8 | GO:2001107 | negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
0.8 | 2.4 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.8 | 3.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.8 | 7.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.8 | 0.8 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.8 | 4.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.8 | 3.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.8 | 2.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.8 | 10.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.8 | 3.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.8 | 30.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.8 | 8.6 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.8 | 2.3 | GO:2000156 | regulation of retrograde vesicle-mediated transport, Golgi to ER(GO:2000156) |
0.8 | 3.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.8 | 26.5 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.8 | 37.3 | GO:0006400 | tRNA modification(GO:0006400) |
0.8 | 31.0 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.8 | 4.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.8 | 2.3 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
0.8 | 10.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.8 | 12.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.8 | 12.3 | GO:0042119 | neutrophil activation(GO:0042119) |
0.8 | 1.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.8 | 2.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.8 | 6.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.8 | 3.0 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.8 | 0.8 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.8 | 4.5 | GO:0002507 | tolerance induction(GO:0002507) |
0.8 | 0.8 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.7 | 12.0 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.7 | 2.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.7 | 14.8 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.7 | 4.4 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.7 | 2.2 | GO:0007315 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.7 | 11.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.7 | 4.4 | GO:0090189 | regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
0.7 | 4.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.7 | 41.0 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.7 | 3.6 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.7 | 6.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.7 | 2.9 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.7 | 0.7 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.7 | 6.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.7 | 21.6 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.7 | 2.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.7 | 5.0 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.7 | 6.4 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.7 | 0.7 | GO:0016246 | RNA interference(GO:0016246) |
0.7 | 7.9 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.7 | 2.8 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.7 | 4.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.7 | 0.7 | GO:0070141 | response to UV-A(GO:0070141) |
0.7 | 7.8 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.7 | 4.2 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.7 | 2.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.7 | 8.4 | GO:0010224 | response to UV-B(GO:0010224) cellular response to UV-B(GO:0071493) |
0.7 | 5.6 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.7 | 4.2 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.7 | 3.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.7 | 4.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.7 | 2.1 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.7 | 3.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.7 | 8.8 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.7 | 1.4 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.7 | 23.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.7 | 7.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.7 | 5.3 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.7 | 3.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.7 | 10.6 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.7 | 8.6 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.7 | 2.0 | GO:0072014 | proximal tubule development(GO:0072014) |
0.7 | 9.8 | GO:0070918 | dsRNA fragmentation(GO:0031050) production of miRNAs involved in gene silencing by miRNA(GO:0035196) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.7 | 2.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.7 | 2.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.7 | 31.2 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.6 | 8.4 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.6 | 0.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.6 | 1.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.6 | 1.9 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.6 | 7.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.6 | 1.3 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.6 | 1.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.6 | 3.9 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.6 | 10.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.6 | 10.9 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.6 | 2.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.6 | 8.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.6 | 1.9 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.6 | 4.4 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.6 | 4.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.6 | 13.3 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.6 | 0.6 | GO:0061056 | sclerotome development(GO:0061056) |
0.6 | 2.5 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.6 | 1.9 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.6 | 6.3 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.6 | 3.2 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.6 | 0.6 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.6 | 2.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.6 | 2.5 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.6 | 5.0 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.6 | 0.6 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.6 | 5.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.6 | 1.2 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.6 | 1.2 | GO:0007494 | midgut development(GO:0007494) Peyer's patch morphogenesis(GO:0061146) |
0.6 | 1.2 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.6 | 1.9 | GO:0009629 | response to gravity(GO:0009629) |
0.6 | 1.2 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.6 | 2.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.6 | 10.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.6 | 90.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.6 | 1.8 | GO:2000299 | negative regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000299) |
0.6 | 2.5 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.6 | 6.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.6 | 1.8 | GO:0021764 | amygdala development(GO:0021764) |
0.6 | 14.6 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.6 | 1.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.6 | 5.5 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.6 | 26.0 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.6 | 1.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.6 | 1.8 | GO:0016131 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.6 | 15.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.6 | 39.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.6 | 3.6 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.6 | 3.6 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.6 | 11.4 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.6 | 2.4 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.6 | 32.8 | GO:0006364 | rRNA processing(GO:0006364) |
0.6 | 2.4 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.6 | 8.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.6 | 67.4 | GO:0006397 | mRNA processing(GO:0006397) |
0.6 | 4.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.6 | 4.1 | GO:0006298 | mismatch repair(GO:0006298) |
0.6 | 2.3 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.6 | 6.4 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.6 | 2.3 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.6 | 1.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.6 | 2.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.6 | 1.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.6 | 5.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.6 | 0.6 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.6 | 0.6 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.6 | 12.6 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.6 | 2.3 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.6 | 1.7 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.6 | 1.7 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.6 | 2.3 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.6 | 3.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.6 | 3.4 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.6 | 3.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.6 | 9.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.6 | 1.1 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.6 | 1.7 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.6 | 2.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.6 | 23.4 | GO:0006304 | DNA modification(GO:0006304) |
0.6 | 5.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.6 | 1.7 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.6 | 3.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.6 | 1.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.5 | 2.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 5.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.5 | 2.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.5 | 5.4 | GO:0015809 | arginine transport(GO:0015809) |
0.5 | 1.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.5 | 2.6 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.5 | 1.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.5 | 4.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.5 | 6.9 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.5 | 4.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 2.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.5 | 6.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.5 | 6.3 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.5 | 2.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.5 | 3.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.5 | 3.6 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.5 | 1.5 | GO:1904093 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
0.5 | 14.8 | GO:0006414 | translational elongation(GO:0006414) |
0.5 | 4.6 | GO:0019985 | translesion synthesis(GO:0019985) |
0.5 | 2.0 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.5 | 1.0 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.5 | 21.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.5 | 3.5 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) |
0.5 | 6.5 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.5 | 14.9 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.5 | 1.5 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.5 | 1.5 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
0.5 | 2.5 | GO:0002159 | desmosome assembly(GO:0002159) |
0.5 | 0.5 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.5 | 1.5 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.5 | 6.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.5 | 3.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.5 | 11.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.5 | 2.9 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.5 | 3.9 | GO:0032369 | negative regulation of lipid transport(GO:0032369) |
0.5 | 1.5 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.5 | 36.2 | GO:0042113 | B cell activation(GO:0042113) |
0.5 | 2.9 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.5 | 1.9 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.5 | 3.8 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.5 | 7.7 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
0.5 | 4.8 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.5 | 1.9 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.5 | 15.3 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.5 | 3.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.5 | 1.9 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.5 | 2.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.5 | 1.4 | GO:0014739 | positive regulation of muscle hyperplasia(GO:0014739) negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.5 | 2.8 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.5 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.5 | 5.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.5 | 22.7 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.5 | 15.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.5 | 5.1 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.5 | 1.4 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.5 | 0.9 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.5 | 2.3 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.5 | 2.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.5 | 5.9 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.5 | 3.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.5 | 2.3 | GO:0061042 | vascular wound healing(GO:0061042) |
0.5 | 2.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.5 | 8.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.5 | 12.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.5 | 4.1 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.4 | 8.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.4 | 0.4 | GO:1902534 | protein targeting to vacuole involved in autophagy(GO:0071211) single-organism membrane invagination(GO:1902534) |
0.4 | 2.2 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) |
0.4 | 3.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 8.5 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.4 | 16.9 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.4 | 4.4 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.4 | 0.9 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.4 | 1.3 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.4 | 2.2 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
0.4 | 17.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.4 | 4.3 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.4 | 1.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.4 | 4.8 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.4 | 4.3 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.4 | 4.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.4 | 2.6 | GO:0033280 | response to vitamin D(GO:0033280) |
0.4 | 12.9 | GO:0045576 | mast cell activation(GO:0045576) |
0.4 | 10.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 | 3.0 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.4 | 2.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.4 | 1.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 2.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.4 | 2.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 0.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 2.9 | GO:0048535 | lymph node development(GO:0048535) |
0.4 | 4.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.4 | 4.2 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.4 | 2.1 | GO:0008228 | opsonization(GO:0008228) |
0.4 | 8.8 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.4 | 0.8 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.4 | 2.5 | GO:1900409 | positive regulation of cellular response to oxidative stress(GO:1900409) |
0.4 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.4 | 0.8 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.4 | 1.7 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.4 | 1.2 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.4 | 4.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 1.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.4 | 2.8 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.4 | 5.7 | GO:1903540 | neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
0.4 | 1.2 | GO:1903911 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of receptor clustering(GO:1903911) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.4 | 2.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 1.6 | GO:0042891 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) |
0.4 | 2.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 6.8 | GO:0007569 | cell aging(GO:0007569) |
0.4 | 2.8 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.4 | 2.0 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.4 | 1.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.4 | 2.3 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.4 | 0.8 | GO:0009301 | snRNA transcription(GO:0009301) |
0.4 | 31.0 | GO:0000910 | cytokinesis(GO:0000910) |
0.4 | 2.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 1.9 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.4 | 2.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.4 | 5.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 6.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.4 | 1.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.4 | 3.4 | GO:0010421 | hydrogen peroxide-mediated programmed cell death(GO:0010421) programmed cell death in response to reactive oxygen species(GO:0097468) regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.4 | 6.0 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.4 | 11.9 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.4 | 10.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.4 | 1.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.4 | 29.2 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
0.4 | 1.1 | GO:0002857 | detection of tumor cell(GO:0002355) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.4 | 2.2 | GO:0046697 | decidualization(GO:0046697) |
0.4 | 1.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.4 | 6.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.4 | 2.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.4 | 1.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.3 | 3.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.3 | 1.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.3 | 2.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.3 | 10.3 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.3 | 1.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 1.7 | GO:1901797 | negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.3 | 1.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.3 | 2.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.3 | 4.1 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.3 | 6.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.3 | 0.7 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.3 | 9.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.3 | 3.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 4.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.3 | 1.0 | GO:0071938 | vitamin A transport(GO:0071938) vitamin A import(GO:0071939) |
0.3 | 1.3 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.3 | 1.3 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.3 | 2.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 2.3 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.3 | 3.2 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
0.3 | 1.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 1.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.3 | 0.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 0.9 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.3 | 0.9 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.3 | 1.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.3 | 2.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.3 | 0.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 1.5 | GO:0009624 | response to nematode(GO:0009624) |
0.3 | 2.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 3.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 13.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.3 | 0.9 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.3 | 2.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 7.2 | GO:0032944 | regulation of mononuclear cell proliferation(GO:0032944) |
0.3 | 1.2 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.3 | 1.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.3 | 0.6 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.3 | 3.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 0.6 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
0.3 | 0.6 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
0.3 | 2.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 0.3 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.3 | 2.8 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.3 | 1.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.3 | 0.3 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
0.3 | 0.3 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.3 | 1.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 1.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 2.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 2.2 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.3 | 1.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 5.1 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.3 | 15.1 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.3 | 2.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 0.5 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.3 | 0.3 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.3 | 2.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.3 | 0.5 | GO:1903333 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.3 | 1.0 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.3 | 2.3 | GO:0032674 | interleukin-5 production(GO:0032634) regulation of interleukin-5 production(GO:0032674) |
0.3 | 2.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.3 | 3.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.3 | 38.0 | GO:0051169 | nuclear transport(GO:0051169) |
0.2 | 0.7 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.2 | 0.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 2.2 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 15.9 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.2 | 4.9 | GO:1900180 | regulation of protein localization to nucleus(GO:1900180) |
0.2 | 0.7 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.2 | 4.7 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.7 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 0.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.5 | GO:0060220 | camera-type eye photoreceptor cell fate commitment(GO:0060220) |
0.2 | 2.7 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.2 | 0.7 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 2.7 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 1.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 1.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 10.9 | GO:0019827 | stem cell population maintenance(GO:0019827) |
0.2 | 3.2 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.2 | 1.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.2 | 2.1 | GO:0042711 | maternal behavior(GO:0042711) |
0.2 | 13.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 0.6 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.2 | 1.4 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 1.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 1.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.8 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.2 | 0.6 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.2 | 0.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.6 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 0.6 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.2 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.8 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.2 | 3.3 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.2 | 1.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.2 | GO:0098534 | centriole assembly(GO:0098534) |
0.2 | 1.2 | GO:0030238 | male sex determination(GO:0030238) |
0.2 | 4.8 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.2 | 1.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 16.7 | GO:0009615 | response to virus(GO:0009615) |
0.2 | 0.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 21.8 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.2 | 0.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 1.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 0.5 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.2 | 5.7 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.2 | 0.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.7 | GO:0071449 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
0.2 | 0.5 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.3 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.2 | 0.9 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.2 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.2 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 1.5 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 0.8 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.3 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 2.1 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.2 | 16.0 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.2 | 0.5 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 2.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 1.4 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 2.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 1.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 2.4 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.2 | 0.3 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.2 | 10.0 | GO:0006260 | DNA replication(GO:0006260) |
0.2 | 0.6 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.2 | 0.8 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.2 | 2.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.9 | GO:0019660 | glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.7 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.9 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 1.6 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 5.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 1.1 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.4 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.1 | 3.0 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.1 | 1.3 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.5 | GO:1903061 | positive regulation of lipoprotein metabolic process(GO:0050747) positive regulation of protein lipidation(GO:1903061) |
0.1 | 0.8 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 1.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 1.4 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 1.9 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 1.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.7 | GO:0031343 | positive regulation of cell killing(GO:0031343) |
0.1 | 0.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.8 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 26.9 | GO:0051301 | cell division(GO:0051301) |
0.1 | 1.3 | GO:0042098 | T cell proliferation(GO:0042098) |
0.1 | 0.8 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 1.9 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.1 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.6 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 2.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.4 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.1 | 0.4 | GO:0015855 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.1 | 0.8 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.6 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.1 | 0.9 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 1.9 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.1 | 3.1 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 0.4 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 1.5 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 1.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 2.4 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 1.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 1.3 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.2 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.8 | GO:0030858 | positive regulation of epithelial cell differentiation(GO:0030858) |
0.1 | 1.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 1.6 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.2 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.1 | 0.1 | GO:2001179 | interleukin-10 secretion(GO:0072608) regulation of interleukin-10 secretion(GO:2001179) |
0.1 | 0.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.3 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 1.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 2.1 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 1.7 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.1 | 0.8 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 7.4 | GO:0001667 | ameboidal-type cell migration(GO:0001667) |
0.1 | 0.1 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.1 | 1.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 1.7 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.1 | 0.1 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.1 | 1.4 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.2 | GO:0009814 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.1 | 4.9 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.7 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.4 | GO:2000351 | regulation of endothelial cell apoptotic process(GO:2000351) positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.1 | GO:0032649 | regulation of interferon-gamma production(GO:0032649) |
0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.3 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 1.7 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.5 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 1.2 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.0 | 0.7 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.5 | GO:0001709 | cell fate determination(GO:0001709) |
0.0 | 0.5 | GO:0060425 | lung morphogenesis(GO:0060425) |
0.0 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.1 | GO:0009644 | response to high light intensity(GO:0009644) |
0.0 | 0.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) sphingoid metabolic process(GO:0046519) |
0.0 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 1.1 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.0 | 0.0 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.5 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.0 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.0 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.0 | 1.0 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.1 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.1 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.9 | 109.4 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
16.3 | 49.0 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
12.3 | 36.9 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
11.5 | 137.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
9.7 | 29.2 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
8.3 | 41.6 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
8.0 | 24.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
7.4 | 148.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
7.4 | 37.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
7.1 | 21.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
7.0 | 27.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
6.6 | 26.4 | GO:0036284 | tubulobulbar complex(GO:0036284) |
6.5 | 45.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
6.4 | 64.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
6.0 | 30.2 | GO:0044194 | cytolytic granule(GO:0044194) |
5.9 | 17.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
5.9 | 70.3 | GO:0005687 | U4 snRNP(GO:0005687) |
5.7 | 28.3 | GO:0000799 | nuclear condensin complex(GO:0000799) |
5.5 | 27.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
5.3 | 21.1 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
5.3 | 26.4 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
5.2 | 15.5 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
5.2 | 62.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
5.1 | 35.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
4.9 | 24.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
4.8 | 14.5 | GO:0097132 | cyclin D2-CDK6 complex(GO:0097132) |
4.8 | 14.4 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
4.7 | 23.7 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
4.6 | 23.1 | GO:0045160 | myosin I complex(GO:0045160) |
4.5 | 4.5 | GO:1990423 | RZZ complex(GO:1990423) |
4.5 | 13.5 | GO:0097224 | sperm connecting piece(GO:0097224) |
4.5 | 31.2 | GO:0036396 | MIS complex(GO:0036396) |
4.3 | 13.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
4.3 | 30.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
4.3 | 4.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
4.2 | 16.9 | GO:0035101 | FACT complex(GO:0035101) |
4.2 | 21.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
4.1 | 66.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
4.1 | 24.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
4.1 | 12.3 | GO:0060187 | cell pole(GO:0060187) |
4.0 | 234.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
4.0 | 327.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
3.9 | 200.7 | GO:0001772 | immunological synapse(GO:0001772) |
3.9 | 23.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
3.8 | 42.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
3.8 | 34.2 | GO:0070652 | HAUS complex(GO:0070652) |
3.8 | 22.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
3.5 | 24.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
3.5 | 24.6 | GO:0000796 | condensin complex(GO:0000796) |
3.5 | 45.3 | GO:0042555 | MCM complex(GO:0042555) |
3.5 | 20.9 | GO:0097342 | ripoptosome(GO:0097342) |
3.5 | 13.9 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
3.4 | 44.8 | GO:0005818 | aster(GO:0005818) |
3.4 | 20.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
3.4 | 10.2 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
3.4 | 27.1 | GO:0097413 | Lewy body(GO:0097413) |
3.3 | 16.7 | GO:0030312 | external encapsulating structure(GO:0030312) |
3.3 | 10.0 | GO:0034455 | t-UTP complex(GO:0034455) |
3.3 | 29.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
3.3 | 9.8 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
3.3 | 55.3 | GO:0090543 | Flemming body(GO:0090543) |
3.2 | 28.7 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
3.2 | 41.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
3.1 | 37.7 | GO:0008278 | cohesin complex(GO:0008278) |
3.1 | 31.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
3.1 | 9.3 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
3.1 | 117.0 | GO:0032040 | small-subunit processome(GO:0032040) |
3.1 | 27.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
3.1 | 15.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
3.0 | 15.2 | GO:0031251 | PAN complex(GO:0031251) |
3.0 | 48.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
3.0 | 9.0 | GO:0070820 | tertiary granule(GO:0070820) |
3.0 | 41.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
3.0 | 6.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
3.0 | 41.6 | GO:0016589 | NURF complex(GO:0016589) |
3.0 | 26.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
3.0 | 20.7 | GO:0098536 | deuterosome(GO:0098536) |
2.9 | 23.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
2.8 | 25.4 | GO:0097427 | microtubule bundle(GO:0097427) |
2.8 | 39.5 | GO:0005686 | U2 snRNP(GO:0005686) |
2.8 | 11.3 | GO:0035061 | interchromatin granule(GO:0035061) |
2.8 | 19.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
2.8 | 8.3 | GO:0018444 | translation release factor complex(GO:0018444) |
2.6 | 18.5 | GO:0089701 | U2AF(GO:0089701) |
2.6 | 7.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
2.6 | 31.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
2.6 | 10.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
2.6 | 13.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
2.6 | 18.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
2.6 | 31.3 | GO:0000801 | central element(GO:0000801) |
2.5 | 7.6 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
2.5 | 5.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
2.5 | 2.5 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
2.5 | 17.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
2.5 | 7.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
2.5 | 32.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.5 | 76.6 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
2.5 | 66.7 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
2.5 | 17.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
2.4 | 131.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
2.4 | 7.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
2.4 | 119.9 | GO:0002102 | podosome(GO:0002102) |
2.3 | 7.0 | GO:1990879 | CST complex(GO:1990879) |
2.3 | 11.4 | GO:0017177 | glucosidase II complex(GO:0017177) |
2.3 | 9.0 | GO:0000974 | Prp19 complex(GO:0000974) |
2.2 | 17.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
2.2 | 6.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
2.2 | 13.2 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
2.2 | 30.6 | GO:0043596 | nuclear replication fork(GO:0043596) |
2.1 | 6.4 | GO:0042382 | paraspeckles(GO:0042382) |
2.1 | 8.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
2.1 | 12.6 | GO:0034709 | methylosome(GO:0034709) |
2.1 | 10.5 | GO:0035339 | SPOTS complex(GO:0035339) |
2.1 | 20.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
2.0 | 10.2 | GO:0000125 | PCAF complex(GO:0000125) |
2.0 | 10.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
2.0 | 33.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
2.0 | 5.9 | GO:0031091 | platelet alpha granule(GO:0031091) |
2.0 | 47.3 | GO:0033202 | DNA helicase complex(GO:0033202) |
2.0 | 11.8 | GO:0005638 | lamin filament(GO:0005638) |
1.9 | 5.8 | GO:0001652 | granular component(GO:0001652) |
1.9 | 15.2 | GO:0070847 | core mediator complex(GO:0070847) |
1.9 | 9.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
1.9 | 13.1 | GO:1990246 | uniplex complex(GO:1990246) |
1.9 | 16.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.9 | 57.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
1.9 | 205.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
1.9 | 37.1 | GO:0070938 | contractile ring(GO:0070938) |
1.8 | 5.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.8 | 3.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.8 | 25.7 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
1.8 | 44.0 | GO:0031527 | filopodium membrane(GO:0031527) |
1.8 | 11.0 | GO:0000502 | proteasome complex(GO:0000502) |
1.8 | 30.6 | GO:0000346 | transcription export complex(GO:0000346) |
1.8 | 10.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.8 | 12.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
1.8 | 16.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.8 | 7.0 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.7 | 17.5 | GO:0005642 | annulate lamellae(GO:0005642) |
1.7 | 207.8 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
1.7 | 52.8 | GO:0005657 | replication fork(GO:0005657) |
1.7 | 8.5 | GO:0043293 | apoptosome(GO:0043293) |
1.7 | 5.1 | GO:1990429 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
1.7 | 5.0 | GO:0055087 | Ski complex(GO:0055087) |
1.7 | 11.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.7 | 1.7 | GO:0005757 | mitochondrial permeability transition pore complex(GO:0005757) |
1.6 | 8.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.6 | 11.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.6 | 4.8 | GO:0000322 | storage vacuole(GO:0000322) |
1.6 | 3.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
1.6 | 8.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.6 | 15.8 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
1.6 | 22.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
1.6 | 3.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
1.6 | 20.2 | GO:0030684 | preribosome(GO:0030684) |
1.5 | 6.0 | GO:0001740 | Barr body(GO:0001740) |
1.5 | 22.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.5 | 4.5 | GO:0034774 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
1.5 | 8.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.5 | 81.3 | GO:0031902 | late endosome membrane(GO:0031902) |
1.5 | 4.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
1.5 | 105.0 | GO:0005871 | kinesin complex(GO:0005871) |
1.5 | 14.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
1.5 | 18.9 | GO:0000791 | euchromatin(GO:0000791) |
1.5 | 10.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.4 | 27.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
1.4 | 60.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.4 | 27.2 | GO:0032433 | filopodium tip(GO:0032433) |
1.4 | 8.5 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
1.4 | 21.2 | GO:0042611 | MHC protein complex(GO:0042611) |
1.4 | 2.8 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
1.4 | 26.4 | GO:0032039 | integrator complex(GO:0032039) |
1.4 | 12.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.4 | 9.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.4 | 5.5 | GO:0008623 | CHRAC(GO:0008623) |
1.4 | 4.1 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
1.3 | 5.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.3 | 4.0 | GO:0016342 | catenin complex(GO:0016342) |
1.3 | 14.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.3 | 8.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.3 | 1.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.3 | 7.9 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
1.3 | 87.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.3 | 13.1 | GO:0001940 | male pronucleus(GO:0001940) |
1.3 | 7.8 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
1.3 | 11.7 | GO:0045298 | tubulin complex(GO:0045298) |
1.3 | 16.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.3 | 29.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.3 | 6.5 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
1.3 | 179.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.3 | 122.2 | GO:0000776 | kinetochore(GO:0000776) |
1.3 | 10.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.2 | 5.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.2 | 3.7 | GO:0034657 | GID complex(GO:0034657) |
1.2 | 4.9 | GO:0032021 | NELF complex(GO:0032021) |
1.2 | 3.7 | GO:0005775 | vacuolar lumen(GO:0005775) |
1.2 | 10.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.2 | 17.0 | GO:0016600 | flotillin complex(GO:0016600) |
1.2 | 13.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.2 | 16.8 | GO:0001673 | male germ cell nucleus(GO:0001673) |
1.2 | 39.4 | GO:0015030 | Cajal body(GO:0015030) |
1.2 | 4.8 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
1.2 | 29.6 | GO:0008305 | integrin complex(GO:0008305) |
1.2 | 16.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
1.1 | 108.1 | GO:0000922 | spindle pole(GO:0000922) |
1.1 | 28.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.1 | 3.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.1 | 3.4 | GO:0036398 | TCR signalosome(GO:0036398) |
1.1 | 2.3 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
1.1 | 32.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.1 | 14.2 | GO:0071203 | WASH complex(GO:0071203) |
1.1 | 10.9 | GO:1990462 | omegasome(GO:1990462) |
1.1 | 11.9 | GO:0042629 | mast cell granule(GO:0042629) |
1.1 | 1.1 | GO:0005607 | laminin-2 complex(GO:0005607) |
1.1 | 5.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.1 | 108.5 | GO:0016605 | PML body(GO:0016605) |
1.1 | 8.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.0 | 3.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.0 | 5.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.0 | 7.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.0 | 8.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.0 | 1.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.0 | 20.3 | GO:0001891 | phagocytic cup(GO:0001891) |
1.0 | 7.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
1.0 | 98.0 | GO:0032587 | ruffle membrane(GO:0032587) |
1.0 | 6.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.0 | 7.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
1.0 | 27.5 | GO:0042588 | zymogen granule(GO:0042588) |
1.0 | 8.8 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
1.0 | 2.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.0 | 1.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.0 | 1.9 | GO:0098833 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
1.0 | 2.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.0 | 7.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.0 | 1.0 | GO:0045293 | mRNA editing complex(GO:0045293) |
1.0 | 12.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.9 | 386.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.9 | 4.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.9 | 29.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.9 | 16.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.9 | 10.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.9 | 3.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.9 | 4.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.9 | 33.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.9 | 9.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.9 | 0.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.9 | 3.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.9 | 2.6 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.8 | 282.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.8 | 0.8 | GO:0061702 | inflammasome complex(GO:0061702) |
0.8 | 2.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.8 | 84.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.8 | 3.2 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.8 | 37.3 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.8 | 4.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.8 | 15.4 | GO:0000145 | exocyst(GO:0000145) |
0.8 | 3.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.8 | 37.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.8 | 40.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.8 | 124.3 | GO:0044452 | nucleolar part(GO:0044452) |
0.8 | 2.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.8 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.8 | 9.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.8 | 3.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.8 | 37.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.7 | 13.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.7 | 5.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.7 | 53.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.7 | 196.2 | GO:0031965 | nuclear membrane(GO:0031965) |
0.7 | 16.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.7 | 2.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.7 | 306.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.7 | 2.1 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.7 | 1.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.7 | 32.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.7 | 8.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.7 | 2.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.7 | 6.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.7 | 2.0 | GO:0010369 | chromocenter(GO:0010369) |
0.6 | 7.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.6 | 217.3 | GO:0000785 | chromatin(GO:0000785) |
0.6 | 10.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.6 | 1.3 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.6 | 1.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.6 | 2.5 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 40.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.6 | 13.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.6 | 2.3 | GO:0031417 | NatC complex(GO:0031417) |
0.6 | 9.3 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.6 | 1.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.6 | 6.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.6 | 14.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.6 | 7.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 65.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.5 | 3.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.5 | 4.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.5 | 2.1 | GO:0071942 | XPC complex(GO:0071942) |
0.5 | 2.1 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.5 | 3.6 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 2.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.5 | 9.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.5 | 7.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.5 | 6.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 29.2 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.5 | 17.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.5 | 1.5 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.5 | 4.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.5 | 3.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.5 | 2.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 3.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 150.0 | GO:0005694 | chromosome(GO:0005694) |
0.5 | 3.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 2.7 | GO:0008091 | spectrin(GO:0008091) |
0.4 | 6.2 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.4 | 3.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 1.8 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.4 | 1.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 3.1 | GO:0048500 | signal recognition particle(GO:0048500) |
0.4 | 1.3 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.4 | 1.3 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.4 | 1.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.4 | 1.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.4 | 5.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 0.4 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 6.0 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.4 | 2.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.4 | 5.0 | GO:0022624 | proteasome regulatory particle(GO:0005838) proteasome accessory complex(GO:0022624) |
0.4 | 19.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 6.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 2.5 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 24.4 | GO:0001726 | ruffle(GO:0001726) |
0.4 | 71.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.4 | 3.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 20.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 1.6 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.4 | 11.6 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 9.6 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.4 | 3.8 | GO:0031932 | TORC2 complex(GO:0031932) |
0.4 | 0.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 3.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 6.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.4 | 0.7 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.4 | 1.8 | GO:0035841 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.4 | 4.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.4 | 3.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.4 | 1.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 1.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.4 | 1.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.4 | 3.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 1.0 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.3 | 6.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 1.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 3.0 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 12.9 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 4.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.3 | 0.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.3 | 124.2 | GO:0005813 | centrosome(GO:0005813) |
0.3 | 8.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 1.7 | GO:0005767 | secondary lysosome(GO:0005767) |
0.3 | 2.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 0.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 2.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 62.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 114.5 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 0.4 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.2 | 0.6 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 1.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 0.6 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.2 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 1.2 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 1.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.2 | 0.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 2.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 15.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.2 | 0.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 1.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 2.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 825.6 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.4 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.9 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.9 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 3.4 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.2 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 1.5 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.9 | 109.4 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
13.7 | 41.1 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
12.2 | 36.6 | GO:0070138 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
12.0 | 59.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
11.4 | 34.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
10.8 | 75.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
9.7 | 29.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
9.5 | 38.1 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
8.8 | 35.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
8.2 | 24.6 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
7.7 | 30.7 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
7.5 | 45.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
7.2 | 35.8 | GO:0019976 | interleukin-2 binding(GO:0019976) |
7.1 | 21.3 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
6.8 | 54.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
6.5 | 32.3 | GO:0019767 | IgE receptor activity(GO:0019767) |
6.4 | 38.5 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
6.3 | 25.0 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
6.2 | 68.3 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
5.7 | 23.0 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
5.7 | 57.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
5.4 | 16.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
5.3 | 32.1 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
5.2 | 15.5 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
5.1 | 87.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
5.1 | 15.2 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
5.0 | 10.0 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
4.9 | 14.7 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
4.6 | 13.9 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
4.6 | 13.8 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
4.6 | 13.7 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
4.5 | 31.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
4.5 | 40.3 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
4.4 | 26.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
4.3 | 13.0 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
4.3 | 51.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
4.3 | 34.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
4.3 | 42.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
4.2 | 16.9 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
4.1 | 12.4 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
4.1 | 20.7 | GO:0030621 | U4 snRNA binding(GO:0030621) |
4.1 | 45.4 | GO:0070990 | snRNP binding(GO:0070990) |
4.1 | 37.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
4.1 | 24.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
4.1 | 12.2 | GO:0035500 | MH2 domain binding(GO:0035500) |
4.0 | 52.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
4.0 | 15.9 | GO:0098770 | FBXO family protein binding(GO:0098770) |
3.9 | 15.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
3.9 | 23.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
3.9 | 46.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
3.9 | 96.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
3.8 | 11.4 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
3.8 | 7.6 | GO:0023023 | MHC protein complex binding(GO:0023023) |
3.8 | 18.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
3.8 | 37.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
3.7 | 11.0 | GO:0019863 | IgE binding(GO:0019863) |
3.7 | 11.0 | GO:0052597 | diamine oxidase activity(GO:0052597) histamine oxidase activity(GO:0052598) methylputrescine oxidase activity(GO:0052599) propane-1,3-diamine oxidase activity(GO:0052600) |
3.7 | 18.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
3.6 | 10.9 | GO:0005174 | CD40 receptor binding(GO:0005174) |
3.6 | 46.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
3.6 | 7.2 | GO:0042497 | triacyl lipopeptide binding(GO:0042497) |
3.6 | 74.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
3.5 | 14.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
3.4 | 10.2 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
3.4 | 10.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
3.4 | 10.1 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
3.2 | 22.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
3.2 | 29.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
3.2 | 15.9 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
3.2 | 12.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
3.1 | 3.1 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
3.1 | 21.7 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
3.0 | 9.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
3.0 | 106.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
3.0 | 9.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
3.0 | 9.0 | GO:0003896 | DNA primase activity(GO:0003896) |
3.0 | 38.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.9 | 8.7 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
2.9 | 8.7 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
2.9 | 14.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
2.8 | 89.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
2.8 | 5.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
2.8 | 11.1 | GO:0072354 | histone kinase activity (H3-T3 specific)(GO:0072354) |
2.8 | 2.8 | GO:0032138 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
2.8 | 8.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
2.8 | 11.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
2.7 | 10.9 | GO:0019809 | spermidine binding(GO:0019809) |
2.7 | 8.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
2.7 | 10.8 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
2.7 | 13.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.7 | 18.6 | GO:0043515 | kinetochore binding(GO:0043515) |
2.6 | 10.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
2.6 | 10.5 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
2.6 | 18.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
2.6 | 10.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
2.5 | 10.2 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
2.5 | 22.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
2.5 | 10.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.5 | 20.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
2.5 | 10.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.5 | 7.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
2.5 | 17.3 | GO:0000339 | RNA cap binding(GO:0000339) |
2.5 | 39.4 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
2.5 | 22.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
2.5 | 2.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
2.4 | 12.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.4 | 12.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
2.4 | 4.8 | GO:0071723 | lipopeptide binding(GO:0071723) |
2.4 | 31.3 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
2.4 | 24.0 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
2.4 | 52.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
2.4 | 54.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
2.4 | 2.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
2.4 | 16.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
2.3 | 32.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
2.3 | 9.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
2.3 | 20.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
2.3 | 2.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
2.3 | 18.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
2.3 | 6.8 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
2.3 | 4.6 | GO:0035877 | death effector domain binding(GO:0035877) |
2.3 | 4.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
2.3 | 9.1 | GO:0036033 | mediator complex binding(GO:0036033) |
2.2 | 6.7 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
2.2 | 76.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
2.2 | 6.7 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
2.2 | 24.5 | GO:0050700 | CARD domain binding(GO:0050700) |
2.2 | 4.4 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
2.2 | 8.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
2.2 | 13.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
2.2 | 10.8 | GO:0031996 | thioesterase binding(GO:0031996) |
2.2 | 10.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
2.2 | 6.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
2.2 | 6.5 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
2.1 | 6.4 | GO:0098808 | mRNA cap binding(GO:0098808) |
2.1 | 2.1 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
2.1 | 6.4 | GO:0070773 | protein-N-terminal glutamine amidohydrolase activity(GO:0070773) |
2.1 | 51.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
2.1 | 8.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
2.1 | 6.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
2.1 | 12.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
2.1 | 48.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
2.1 | 6.2 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
2.1 | 6.2 | GO:0030338 | CMP-N-acetylneuraminate monooxygenase activity(GO:0030338) |
2.1 | 4.1 | GO:0043532 | angiostatin binding(GO:0043532) |
2.1 | 14.4 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
2.1 | 8.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
2.0 | 2.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.0 | 16.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.0 | 24.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
2.0 | 6.1 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
2.0 | 36.0 | GO:0043495 | protein anchor(GO:0043495) |
2.0 | 6.0 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
2.0 | 7.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.0 | 13.9 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
2.0 | 11.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
2.0 | 17.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
2.0 | 108.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
2.0 | 25.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
2.0 | 5.9 | GO:0019978 | interleukin-3 receptor activity(GO:0004912) interleukin-3 binding(GO:0019978) |
1.9 | 11.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.9 | 97.1 | GO:0019843 | rRNA binding(GO:0019843) |
1.9 | 7.7 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.9 | 19.1 | GO:0050733 | RS domain binding(GO:0050733) |
1.9 | 9.6 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
1.9 | 1.9 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.9 | 5.7 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
1.9 | 13.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
1.9 | 5.7 | GO:0032357 | oxidized purine DNA binding(GO:0032357) |
1.9 | 62.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.9 | 30.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.9 | 9.4 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.9 | 9.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
1.9 | 5.6 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
1.8 | 1.8 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
1.8 | 1.8 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
1.8 | 53.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.8 | 11.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.8 | 1.8 | GO:0048256 | flap endonuclease activity(GO:0048256) |
1.8 | 1.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.8 | 12.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.8 | 21.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
1.8 | 10.8 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
1.8 | 70.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.8 | 10.8 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.8 | 5.4 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.8 | 1.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.8 | 48.0 | GO:0031491 | nucleosome binding(GO:0031491) |
1.8 | 23.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
1.8 | 5.3 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
1.8 | 28.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.8 | 5.3 | GO:0001096 | TFIIF-class transcription factor binding(GO:0001096) |
1.8 | 12.3 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
1.8 | 57.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
1.7 | 3.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
1.7 | 10.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
1.7 | 12.1 | GO:0038132 | neuregulin binding(GO:0038132) |
1.7 | 10.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.7 | 20.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.7 | 36.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.7 | 5.2 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
1.7 | 8.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.7 | 17.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
1.7 | 13.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
1.7 | 213.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.7 | 8.4 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.7 | 267.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
1.7 | 5.0 | GO:0003999 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
1.7 | 11.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
1.7 | 21.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.7 | 6.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.7 | 9.9 | GO:0032810 | sterol response element binding(GO:0032810) |
1.7 | 69.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.6 | 6.6 | GO:0089720 | caspase binding(GO:0089720) |
1.6 | 8.1 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
1.6 | 6.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.6 | 4.9 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
1.6 | 9.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.6 | 4.8 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
1.6 | 4.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
1.6 | 4.8 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.6 | 11.1 | GO:1990254 | keratin filament binding(GO:1990254) |
1.6 | 14.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.6 | 39.3 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
1.6 | 17.3 | GO:0033691 | sialic acid binding(GO:0033691) |
1.6 | 29.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.6 | 18.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.5 | 10.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.5 | 18.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.5 | 9.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
1.5 | 13.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.5 | 21.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.5 | 15.3 | GO:0004064 | arylesterase activity(GO:0004064) |
1.5 | 96.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.5 | 36.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.5 | 22.5 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
1.5 | 16.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.5 | 93.5 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
1.5 | 5.9 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
1.5 | 10.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.5 | 10.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.5 | 10.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
1.5 | 14.6 | GO:0050692 | DBD domain binding(GO:0050692) |
1.5 | 4.4 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
1.4 | 4.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
1.4 | 17.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
1.4 | 13.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.4 | 4.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
1.4 | 56.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.4 | 7.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
1.4 | 11.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.4 | 4.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.4 | 10.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.4 | 8.5 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
1.4 | 8.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.4 | 16.9 | GO:0005123 | death receptor binding(GO:0005123) |
1.4 | 2.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.4 | 19.7 | GO:0030274 | LIM domain binding(GO:0030274) |
1.4 | 95.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.4 | 4.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.4 | 22.4 | GO:0005522 | profilin binding(GO:0005522) |
1.4 | 4.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
1.4 | 2.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.4 | 49.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
1.4 | 6.9 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
1.4 | 4.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
1.4 | 32.6 | GO:0008143 | poly(A) binding(GO:0008143) |
1.3 | 4.0 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
1.3 | 38.7 | GO:0001968 | fibronectin binding(GO:0001968) |
1.3 | 4.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.3 | 10.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.3 | 17.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
1.3 | 85.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
1.3 | 34.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.3 | 1.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
1.3 | 19.7 | GO:0046977 | TAP binding(GO:0046977) |
1.3 | 3.9 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
1.3 | 5.2 | GO:0019961 | interferon binding(GO:0019961) |
1.3 | 29.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.3 | 7.7 | GO:0048495 | Roundabout binding(GO:0048495) |
1.3 | 5.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
1.3 | 10.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.3 | 3.8 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
1.3 | 3.8 | GO:0035375 | zymogen binding(GO:0035375) |
1.2 | 31.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
1.2 | 42.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
1.2 | 11.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.2 | 3.7 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
1.2 | 21.9 | GO:0043274 | phospholipase binding(GO:0043274) |
1.2 | 6.0 | GO:0042287 | MHC protein binding(GO:0042287) |
1.2 | 7.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.2 | 22.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.2 | 65.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.2 | 45.3 | GO:0004527 | exonuclease activity(GO:0004527) |
1.2 | 11.9 | GO:0030957 | Tat protein binding(GO:0030957) |
1.2 | 47.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.2 | 3.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.2 | 5.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.2 | 6.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.2 | 12.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.1 | 3.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.1 | 2.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.1 | 13.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
1.1 | 16.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.1 | 3.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
1.1 | 4.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
1.1 | 3.4 | GO:0032093 | SAM domain binding(GO:0032093) |
1.1 | 33.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
1.1 | 11.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.1 | 6.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.1 | 55.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
1.1 | 4.5 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
1.1 | 54.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.1 | 11.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
1.1 | 6.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
1.1 | 8.9 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
1.1 | 9.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.1 | 4.4 | GO:0045159 | myosin II binding(GO:0045159) |
1.1 | 1.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.1 | 10.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.1 | 6.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
1.1 | 27.9 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
1.1 | 7.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.1 | 2.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
1.1 | 44.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
1.1 | 14.9 | GO:0030515 | snoRNA binding(GO:0030515) |
1.1 | 4.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.1 | 27.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.0 | 7.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.0 | 3.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
1.0 | 6.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.0 | 3.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
1.0 | 19.6 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
1.0 | 4.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
1.0 | 3.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) BLOC-2 complex binding(GO:0036461) |
1.0 | 6.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
1.0 | 25.7 | GO:0001618 | virus receptor activity(GO:0001618) |
1.0 | 7.2 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
1.0 | 4.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.0 | 2.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
1.0 | 6.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.0 | 4.0 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
1.0 | 5.0 | GO:0030911 | TPR domain binding(GO:0030911) |
1.0 | 5.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.0 | 33.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.0 | 6.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) |
1.0 | 9.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.0 | 72.4 | GO:0035064 | methylated histone binding(GO:0035064) |
1.0 | 4.9 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
1.0 | 1.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.0 | 60.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.0 | 1.0 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
1.0 | 2.9 | GO:0090556 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.0 | 5.8 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.0 | 2.9 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
1.0 | 7.7 | GO:0045545 | syndecan binding(GO:0045545) |
1.0 | 3.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.0 | 9.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.9 | 2.8 | GO:0016232 | HNK-1 sulfotransferase activity(GO:0016232) |
0.9 | 5.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.9 | 9.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.9 | 4.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.9 | 18.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.9 | 0.9 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.9 | 1.8 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
0.9 | 11.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.9 | 8.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.9 | 6.3 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.9 | 8.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.9 | 8.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.9 | 4.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.9 | 8.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.9 | 9.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.9 | 27.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.9 | 4.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.9 | 14.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.9 | 0.9 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.9 | 0.9 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.9 | 3.4 | GO:0051435 | BH4 domain binding(GO:0051435) |
0.9 | 4.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) sterol-transporting ATPase activity(GO:0034041) |
0.8 | 45.0 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.8 | 0.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.8 | 22.9 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.8 | 4.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.8 | 4.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.8 | 4.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.8 | 14.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.8 | 1.6 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.8 | 42.1 | GO:0004386 | helicase activity(GO:0004386) |
0.8 | 13.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.8 | 12.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.8 | 4.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.8 | 8.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.8 | 147.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.8 | 3.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.8 | 3.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.8 | 3.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.8 | 7.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.8 | 19.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.8 | 3.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.8 | 2.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.8 | 51.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.8 | 8.5 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.8 | 3.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.8 | 35.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.8 | 1.5 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.8 | 12.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.8 | 4.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.7 | 3.7 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.7 | 5.2 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.7 | 86.0 | GO:0042393 | histone binding(GO:0042393) |
0.7 | 7.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.7 | 1.5 | GO:0036004 | GAF domain binding(GO:0036004) |
0.7 | 79.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.7 | 1.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.7 | 5.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.7 | 5.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.7 | 14.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.7 | 5.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.7 | 2.9 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.7 | 1.5 | GO:0070976 | TIR domain binding(GO:0070976) |
0.7 | 10.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.7 | 2.9 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.7 | 2.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.7 | 4.3 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.7 | 17.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.7 | 2.1 | GO:0071820 | N-box binding(GO:0071820) |
0.7 | 8.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 2.8 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.7 | 2.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.7 | 2.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.7 | 169.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.7 | 30.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.7 | 3.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.7 | 11.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.7 | 19.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.7 | 1.4 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.7 | 8.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.7 | 2.7 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.7 | 4.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.7 | 1.3 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.7 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.7 | 4.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.7 | 11.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.7 | 6.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.7 | 2.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.6 | 21.4 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.6 | 7.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.6 | 142.2 | GO:0001047 | core promoter binding(GO:0001047) |
0.6 | 71.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.6 | 1.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 15.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 9.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.6 | 42.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.6 | 6.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.6 | 37.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.6 | 202.8 | GO:0045296 | cadherin binding(GO:0045296) |
0.6 | 1.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.6 | 3.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.6 | 16.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.6 | 1.8 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.6 | 2.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.6 | 21.7 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.6 | 1.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.6 | 10.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.6 | 4.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.6 | 19.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.6 | 73.9 | GO:0005178 | integrin binding(GO:0005178) |
0.6 | 1.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.6 | 8.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.6 | 10.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.6 | 5.2 | GO:0052744 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.6 | 2.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.6 | 2.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.6 | 688.8 | GO:0003723 | RNA binding(GO:0003723) |
0.6 | 1.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.6 | 2.3 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.6 | 1.7 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.6 | 3.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.6 | 0.6 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.6 | 4.5 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.6 | 1.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.6 | 5.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.6 | 2.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.5 | 6.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.5 | 1.6 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.5 | 3.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.5 | 4.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.5 | 7.1 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 4.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.5 | 6.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.5 | 3.2 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.5 | 3.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.5 | 1.6 | GO:0004512 | inositol-3-phosphate synthase activity(GO:0004512) intramolecular lyase activity(GO:0016872) |
0.5 | 2.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.5 | 0.5 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.5 | 10.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.5 | 2.6 | GO:0070728 | leucine binding(GO:0070728) |
0.5 | 11.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.5 | 6.2 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.5 | 2.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.5 | 2.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.5 | 2.0 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.5 | 2.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.5 | 2.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.5 | 24.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.5 | 39.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.5 | 5.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.5 | 3.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.5 | 10.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 2.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.5 | 5.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.5 | 7.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.5 | 3.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.5 | 0.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 2.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.5 | 3.3 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.5 | 10.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.5 | 1.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 11.9 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.5 | 6.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.5 | 3.2 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.5 | 1.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.5 | 7.3 | GO:0043531 | ADP binding(GO:0043531) |
0.5 | 1.4 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.5 | 38.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.4 | 2.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 4.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.4 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 1.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.4 | 3.5 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.4 | 3.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 9.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.4 | 75.9 | GO:0019902 | phosphatase binding(GO:0019902) |
0.4 | 18.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.4 | 12.9 | GO:0002039 | p53 binding(GO:0002039) |
0.4 | 1.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 6.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.4 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 11.2 | GO:0008009 | chemokine activity(GO:0008009) |
0.4 | 0.8 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.4 | 12.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 1.6 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.4 | 113.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.4 | 5.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.4 | 7.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 1.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 23.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 2.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.4 | 0.8 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 8.8 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.4 | 0.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 3.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 1.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.4 | 1.5 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.4 | 632.8 | GO:0003677 | DNA binding(GO:0003677) |
0.4 | 2.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 1.8 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.4 | 0.7 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.4 | 1.8 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.4 | 5.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.4 | 1.4 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.4 | 10.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 5.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 4.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 1.0 | GO:0001607 | neuromedin U receptor activity(GO:0001607) |
0.3 | 4.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 3.3 | GO:0031386 | protein tag(GO:0031386) |
0.3 | 4.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 17.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 4.1 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 15.3 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.3 | 1.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 1.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 11.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 9.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 3.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 1.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 2.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 0.6 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 0.3 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.3 | 0.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 1.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 0.9 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.3 | 2.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 1.9 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.3 | 1.4 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.3 | 1.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 0.8 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.3 | 0.5 | GO:0032554 | deoxyribonucleotide binding(GO:0032552) purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.3 | 1.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 6.2 | GO:0004601 | peroxidase activity(GO:0004601) |
0.2 | 49.5 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 0.5 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.2 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 3.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 4.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 1.4 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.2 | 1.6 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 1.6 | GO:0015265 | urea channel activity(GO:0015265) |
0.2 | 0.4 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 6.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 1.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.2 | 0.6 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.2 | 0.4 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.2 | 1.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.9 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 28.1 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.2 | 3.3 | GO:0019213 | deacetylase activity(GO:0019213) |
0.2 | 5.9 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.2 | 0.6 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.2 | 0.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 2.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 4.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 1.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 6.8 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 0.6 | GO:0050354 | glycerone kinase activity(GO:0004371) FAD-AMP lyase (cyclizing) activity(GO:0034012) triokinase activity(GO:0050354) |
0.2 | 1.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.8 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 1.0 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.2 | 1.1 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 3.4 | GO:0008253 | nucleotidase activity(GO:0008252) 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 2.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.6 | GO:0019239 | deaminase activity(GO:0019239) |
0.2 | 0.5 | GO:0008775 | acetate CoA-transferase activity(GO:0008775) |
0.1 | 0.6 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
0.1 | 18.2 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 1.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 8.0 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 6.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 2.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 3.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 1.0 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 0.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 1.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.1 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.1 | 0.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 3.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 3.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 3.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 5.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 1.4 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 1.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 2.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.3 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.1 | 0.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.6 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.1 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 17.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 2.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.2 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.1 | 0.2 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) N-acetylglucosamine kinase activity(GO:0045127) |
0.1 | 0.5 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 1.5 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.4 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 24.8 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 2.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.1 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.1 | 0.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.0 | 0.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.0 | 0.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 3.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 3.6 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 2.6 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.0 | 0.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.9 | GO:0008565 | protein transporter activity(GO:0008565) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.1 | 32.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
5.1 | 468.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
4.8 | 4.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
4.6 | 160.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
4.6 | 73.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
3.1 | 85.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
2.9 | 171.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.8 | 196.5 | PID PLK1 PATHWAY | PLK1 signaling events |
2.6 | 133.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
2.5 | 64.5 | PID ATR PATHWAY | ATR signaling pathway |
2.3 | 123.4 | PID BCR 5PATHWAY | BCR signaling pathway |
2.2 | 76.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
2.1 | 90.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
2.1 | 27.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
2.1 | 27.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.9 | 58.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.9 | 153.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.8 | 5.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.8 | 18.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.8 | 58.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.8 | 95.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.8 | 47.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
1.7 | 73.4 | PID AURORA B PATHWAY | Aurora B signaling |
1.7 | 8.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.7 | 53.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.7 | 3.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.7 | 3.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.6 | 9.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.6 | 101.4 | PID P53 REGULATION PATHWAY | p53 pathway |
1.6 | 46.2 | PID MYC PATHWAY | C-MYC pathway |
1.6 | 64.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.5 | 21.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.5 | 94.4 | PID E2F PATHWAY | E2F transcription factor network |
1.5 | 75.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
1.4 | 45.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.4 | 16.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.4 | 63.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.3 | 36.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.3 | 2.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.3 | 48.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.3 | 79.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.2 | 55.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.2 | 34.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
1.2 | 16.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.2 | 20.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.1 | 6.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
1.0 | 14.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.0 | 6.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.0 | 3.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.0 | 12.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
1.0 | 7.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.0 | 11.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.0 | 2.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.0 | 41.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.0 | 91.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.9 | 58.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.9 | 17.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.9 | 5.5 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.9 | 1.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.9 | 96.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.8 | 5.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.8 | 9.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.8 | 8.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.8 | 66.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.8 | 42.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.8 | 12.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.8 | 12.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.7 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.7 | 44.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.7 | 5.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.7 | 12.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.7 | 17.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.7 | 10.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.7 | 18.0 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.7 | 47.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.7 | 20.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.7 | 11.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.6 | 67.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.6 | 6.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.6 | 5.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.6 | 6.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.5 | 2.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 8.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.5 | 4.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.5 | 3.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.5 | 11.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.5 | 7.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.5 | 3.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 8.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 4.4 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 4.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 23.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 14.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 4.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 32.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.4 | 4.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.4 | 1.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.4 | 14.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 8.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 10.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 9.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 3.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 12.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 2.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 54.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 9.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 2.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 0.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 1.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 3.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 4.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 2.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 2.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 4.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 6.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 3.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 5.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 2.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 7.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 3.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 2.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 12.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 8.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.5 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.7 | 172.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
6.1 | 36.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
5.9 | 93.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
5.7 | 57.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
5.6 | 39.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
5.6 | 72.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
5.1 | 36.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
5.0 | 5.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
4.8 | 276.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
4.6 | 97.2 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
4.5 | 552.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
4.3 | 51.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
4.3 | 76.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
4.1 | 8.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
3.9 | 85.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
3.8 | 88.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
3.7 | 14.7 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
3.5 | 73.5 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
3.5 | 35.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
3.3 | 110.0 | REACTOME KINESINS | Genes involved in Kinesins |
3.2 | 25.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
3.2 | 60.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
3.1 | 31.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
3.1 | 6.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
2.9 | 143.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
2.9 | 40.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
2.7 | 11.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.7 | 29.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
2.6 | 62.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
2.6 | 51.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
2.6 | 48.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
2.6 | 43.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
2.6 | 153.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.5 | 5.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
2.5 | 79.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
2.5 | 19.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
2.4 | 31.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
2.4 | 41.1 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
2.4 | 72.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
2.4 | 61.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
2.3 | 9.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
2.3 | 119.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
2.1 | 59.7 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
2.1 | 4.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
2.1 | 46.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
2.1 | 4.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
2.0 | 179.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
2.0 | 24.0 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
2.0 | 9.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
2.0 | 23.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
1.9 | 34.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
1.9 | 52.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.9 | 26.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.8 | 42.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
1.8 | 21.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.7 | 22.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.7 | 41.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.7 | 54.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.7 | 1.7 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
1.6 | 21.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.6 | 22.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
1.6 | 63.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
1.6 | 65.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
1.5 | 30.8 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
1.5 | 41.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.5 | 1.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.5 | 29.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.5 | 29.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.5 | 13.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.5 | 14.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.4 | 22.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.4 | 24.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.3 | 102.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.3 | 26.1 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
1.3 | 2.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.3 | 16.3 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
1.2 | 5.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.2 | 66.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
1.2 | 23.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.2 | 13.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.1 | 25.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.1 | 4.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.1 | 34.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.1 | 16.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
1.0 | 6.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.0 | 44.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.0 | 3.9 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
1.0 | 83.5 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.9 | 16.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.9 | 14.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.9 | 19.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.9 | 32.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.9 | 21.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.9 | 37.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.9 | 9.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.9 | 20.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.9 | 2.6 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.9 | 15.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.9 | 1.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.8 | 24.5 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.8 | 7.6 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.8 | 26.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.8 | 3.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.8 | 40.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.8 | 39.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.8 | 13.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.8 | 6.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.8 | 99.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.8 | 3.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.8 | 52.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.8 | 16.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.8 | 5.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.7 | 0.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.7 | 28.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.7 | 15.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.7 | 11.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.7 | 51.2 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.7 | 20.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.7 | 43.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.7 | 7.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.7 | 24.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.7 | 4.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 10.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.6 | 9.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.6 | 5.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.6 | 18.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.6 | 34.1 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.6 | 17.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.5 | 24.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 10.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.5 | 11.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.5 | 3.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 8.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.5 | 13.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.5 | 11.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.5 | 20.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.5 | 13.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 4.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 3.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 42.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.4 | 6.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.4 | 14.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 9.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.4 | 5.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.4 | 1.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.4 | 2.6 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.4 | 1.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 22.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.4 | 31.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 3.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 1.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.3 | 2.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.3 | 10.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 5.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 1.3 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 1.0 | REACTOME ADAPTIVE IMMUNE SYSTEM | Genes involved in Adaptive Immune System |
0.3 | 1.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 6.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 13.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 1.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 5.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.3 | 3.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 11.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 4.5 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.3 | 4.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 6.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 2.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 5.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 2.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 3.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 3.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 2.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 4.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 3.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 3.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 24.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 3.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 2.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 8.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 1.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 12.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.6 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 2.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.7 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 5.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 1.9 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 7.8 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 0.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |